| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | HSPG2 RELN FBLN5 LAMA1 LAMA2 LAMA5 LAMC2 TECTA CRELD1 FBLN1 FBN1 NID1 LTBP1 LTBP2 MUC2 LTBP4 MUC5AC FBN3 | 1.58e-18 | 188 | 98 | 18 | GO:0005201 |
| GeneOntologyMolecularFunction | calcium ion binding | TPO HSPG2 FBLN5 CD248 BCAN EFHB LRP1B RYR3 CRB1 CRELD1 THBD FBLN1 FBN1 SCUBE2 MEGF6 JAG1 LRP2 C1R NID1 LTBP1 LTBP2 VWA2 LTBP4 FBN3 NOTCH2 NOTCH3 OC90 PROS1 | 1.56e-17 | 749 | 98 | 28 | GO:0005509 |
| GeneOntologyMolecularFunction | structural molecule activity | HSPG2 RELN FBLN5 MAP1B LAMA1 LAMA2 LAMA5 LAMC2 TECTA CRELD1 FBLN1 FBN1 JAG1 NID1 LTBP1 LTBP2 MUC2 LTBP4 MUC5AC FBN3 OC90 OTOG | 2.67e-10 | 891 | 98 | 22 | GO:0005198 |
| GeneOntologyMolecularFunction | alpha-L-arabinofuranosidase activity | 2.38e-05 | 2 | 98 | 2 | GO:0046556 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 6.18e-05 | 85 | 98 | 5 | GO:0019199 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 7.42e-05 | 17 | 98 | 3 | GO:0042813 | |
| GeneOntologyMolecularFunction | integrin binding | 2.25e-04 | 175 | 98 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | mannosyltransferase activity | 3.44e-04 | 28 | 98 | 3 | GO:0000030 | |
| GeneOntologyMolecularFunction | microfibril binding | 3.53e-04 | 6 | 98 | 2 | GO:0050436 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 4.58e-04 | 73 | 98 | 4 | GO:0050840 | |
| GeneOntologyMolecularFunction | Wnt-protein binding | 6.14e-04 | 34 | 98 | 3 | GO:0017147 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 9.22e-04 | 39 | 98 | 3 | GO:0070325 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 1.52e-03 | 12 | 98 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity | 1.80e-03 | 13 | 98 | 2 | GO:0005024 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 2.08e-03 | 268 | 98 | 6 | GO:0005539 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 2.09e-03 | 14 | 98 | 2 | GO:0097493 | |
| GeneOntologyBiologicalProcess | neuron development | DHX36 HSPG2 RELN MAP1B ROR1 LAMA1 LAMA2 LAMA5 PRPH2 LAMC2 BCAN TECTA CRB1 SEPTIN2 OTOGL P3H1 LRP2 ALK EPHA10 NOTCH2 NOTCH3 OTOG | 8.84e-07 | 1463 | 97 | 22 | GO:0048666 |
| GeneOntologyBiologicalProcess | axon guidance | HSPG2 RELN LAMA1 LAMA2 LAMA5 LAMC2 LRP2 EPHA10 NOTCH2 NOTCH3 | 9.46e-07 | 285 | 97 | 10 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | HSPG2 RELN LAMA1 LAMA2 LAMA5 LAMC2 LRP2 EPHA10 NOTCH2 NOTCH3 | 9.76e-07 | 286 | 97 | 10 | GO:0097485 |
| GeneOntologyBiologicalProcess | neuron projection development | DHX36 HSPG2 RELN MAP1B ROR1 LAMA1 LAMA2 LAMA5 LAMC2 BCAN TECTA SEPTIN2 OTOGL P3H1 LRP2 ALK EPHA10 NOTCH2 NOTCH3 OTOG | 1.82e-06 | 1285 | 97 | 20 | GO:0031175 |
| GeneOntologyBiologicalProcess | peptidyl-tryptophan modification | 2.00e-06 | 6 | 97 | 3 | GO:0018211 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation via tryptophan | 2.00e-06 | 6 | 97 | 3 | GO:0018317 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan | 2.00e-06 | 6 | 97 | 3 | GO:0018406 | |
| GeneOntologyBiologicalProcess | protein C-linked glycosylation | 2.00e-06 | 6 | 97 | 3 | GO:0018103 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 3.60e-06 | 410 | 97 | 11 | GO:0031589 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | HSPG2 FBLN5 LAMA1 LAMA2 FBLN1 P3H1 ADAMTS20 NID1 LTBP4 SPINK5 | 1.13e-05 | 377 | 97 | 10 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | HSPG2 FBLN5 LAMA1 LAMA2 FBLN1 P3H1 ADAMTS20 NID1 LTBP4 SPINK5 | 1.16e-05 | 378 | 97 | 10 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | HSPG2 FBLN5 LAMA1 LAMA2 FBLN1 P3H1 ADAMTS20 NID1 LTBP4 SPINK5 | 1.18e-05 | 379 | 97 | 10 | GO:0045229 |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 1.62e-05 | 11 | 97 | 3 | GO:0110011 | |
| GeneOntologyBiologicalProcess | arabinose metabolic process | 2.19e-05 | 2 | 97 | 2 | GO:0019566 | |
| GeneOntologyBiologicalProcess | vibrational conductance of sound to the inner ear | 2.19e-05 | 2 | 97 | 2 | GO:0055127 | |
| GeneOntologyBiologicalProcess | L-arabinose metabolic process | 2.19e-05 | 2 | 97 | 2 | GO:0046373 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 2.64e-05 | 124 | 97 | 6 | GO:0007229 | |
| GeneOntologyBiologicalProcess | bone development | 3.50e-05 | 264 | 97 | 8 | GO:0060348 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 3.53e-05 | 14 | 97 | 3 | GO:2001046 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 4.11e-05 | 270 | 97 | 8 | GO:0007160 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | DHX36 HSPG2 RELN MAP1B LAMA1 LAMA2 LAMA5 LAMC2 TECTA LRP2 EPHA10 NOTCH2 NOTCH3 | 4.76e-05 | 748 | 97 | 13 | GO:0048667 |
| GeneOntologyBiologicalProcess | axonogenesis | HSPG2 RELN MAP1B LAMA1 LAMA2 LAMA5 LAMC2 LRP2 EPHA10 NOTCH2 NOTCH3 | 7.11e-05 | 566 | 97 | 11 | GO:0007409 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | DHX36 HSPG2 RELN MAP1B LAMA1 LAMA2 LAMA5 LAMC2 BCAN LRP2 EPHA10 NOTCH2 NOTCH3 | 9.63e-05 | 802 | 97 | 13 | GO:0048812 |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 1.05e-04 | 99 | 97 | 5 | GO:0045995 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | DHX36 HSPG2 RELN MAP1B LAMA1 LAMA2 LAMA5 LAMC2 BCAN LRP2 EPHA10 NOTCH2 NOTCH3 | 1.19e-04 | 819 | 97 | 13 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | DHX36 HSPG2 RELN MAP1B LAMA1 LAMA2 LAMA5 LAMC2 BCAN LRP2 EPHA10 NOTCH2 NOTCH3 | 1.29e-04 | 826 | 97 | 13 | GO:0048858 |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 1.31e-04 | 4 | 97 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | DHX36 HSPG2 RELN MAP1B LAMA1 LAMA2 LAMA5 LAMC2 BCAN TECTA CRB1 LRP2 PXN EPHA10 NOTCH2 NOTCH3 | 1.35e-04 | 1194 | 97 | 16 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 1.67e-04 | 23 | 97 | 3 | GO:2001044 | |
| GeneOntologyBiologicalProcess | axon development | HSPG2 RELN MAP1B LAMA1 LAMA2 LAMA5 LAMC2 LRP2 EPHA10 NOTCH2 NOTCH3 | 2.14e-04 | 642 | 97 | 11 | GO:0061564 |
| GeneOntologyBiologicalProcess | protein mannosylation | 2.15e-04 | 25 | 97 | 3 | GO:0035268 | |
| GeneOntologyBiologicalProcess | detection of light stimulus involved in visual perception | 2.15e-04 | 25 | 97 | 3 | GO:0050908 | |
| GeneOntologyBiologicalProcess | detection of light stimulus involved in sensory perception | 2.15e-04 | 25 | 97 | 3 | GO:0050962 | |
| GeneOntologyBiologicalProcess | mannosylation | 2.42e-04 | 26 | 97 | 3 | GO:0097502 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature morphogenesis | 3.24e-04 | 6 | 97 | 2 | GO:0072103 | |
| GeneOntologyBiologicalProcess | glomerular capillary formation | 3.24e-04 | 6 | 97 | 2 | GO:0072104 | |
| GeneOntologyBiologicalProcess | ciliary body morphogenesis | 3.24e-04 | 6 | 97 | 2 | GO:0061073 | |
| GeneOntologyBiologicalProcess | pulmonary artery morphogenesis | 3.24e-04 | 6 | 97 | 2 | GO:0061156 | |
| GeneOntologyBiologicalProcess | fibrinolysis | 3.37e-04 | 29 | 97 | 3 | GO:0042730 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 3.57e-04 | 199 | 97 | 6 | GO:0051147 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 4.29e-04 | 134 | 97 | 5 | GO:0003279 | |
| GeneOntologyBiologicalProcess | renal system vasculature morphogenesis | 4.53e-04 | 7 | 97 | 2 | GO:0061438 | |
| GeneOntologyBiologicalProcess | kidney vasculature morphogenesis | 4.53e-04 | 7 | 97 | 2 | GO:0061439 | |
| GeneOntologyBiologicalProcess | glomerulus development | 4.78e-04 | 77 | 97 | 4 | GO:0032835 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 6.02e-04 | 8 | 97 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | skeletal system development | HSPG2 FBLN5 LAMA5 BCAN FREM1 FBN1 SCUBE2 PHOSPHO1 P3H1 NOTCH2 | 6.32e-04 | 615 | 97 | 10 | GO:0001501 |
| GeneOntologyBiologicalProcess | sensory organ development | ROR1 LAMA1 PRPH2 TECTA GRM6 CRB1 OTOGL JAG1 NOTCH2 OC90 OTOG | 6.34e-04 | 730 | 97 | 11 | GO:0007423 |
| GeneOntologyBiologicalProcess | glomerular epithelial cell development | 9.61e-04 | 10 | 97 | 2 | GO:0072310 | |
| GeneOntologyBiologicalProcess | podocyte development | 9.61e-04 | 10 | 97 | 2 | GO:0072015 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 1.09e-03 | 43 | 97 | 3 | GO:0071711 | |
| GeneOntologyBiologicalProcess | salivary gland development | 1.09e-03 | 43 | 97 | 3 | GO:0007431 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 1.10e-03 | 96 | 97 | 4 | GO:0060113 | |
| GeneOntologyBiologicalProcess | glomerulus morphogenesis | 1.17e-03 | 11 | 97 | 2 | GO:0072102 | |
| GeneOntologyBiologicalProcess | antibacterial innate immune response | 1.17e-03 | 11 | 97 | 2 | GO:0140367 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 1.17e-03 | 11 | 97 | 2 | GO:0035581 | |
| GeneOntologyBiologicalProcess | elastic fiber assembly | 1.17e-03 | 11 | 97 | 2 | GO:0048251 | |
| GeneOntologyBiologicalProcess | inner ear development | 1.25e-03 | 253 | 97 | 6 | GO:0048839 | |
| GeneOntologyBiologicalProcess | regulation of neuron differentiation | 1.30e-03 | 255 | 97 | 6 | GO:0045664 | |
| GeneOntologyBiologicalProcess | nephron development | 1.39e-03 | 174 | 97 | 5 | GO:0072006 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, cholinergic | 1.40e-03 | 12 | 97 | 2 | GO:0032224 | |
| GeneOntologyBiologicalProcess | mechanoreceptor differentiation | 1.48e-03 | 104 | 97 | 4 | GO:0042490 | |
| GeneOntologyCellularComponent | extracellular matrix | HSPG2 RELN FBLN5 CD248 LAMA1 LAMA2 LAMA5 LAMC2 BCAN TECTA ELFN2 FREM1 CRELD1 FBLN1 FBN1 FCGBP PHOSPHO1 MEGF6 OTOGL P3H1 ADAMTS20 NID1 PLAT LTBP1 LTBP2 MUC2 VWA2 LTBP4 MUC5AC FBN3 OC90 OTOG | 3.51e-24 | 656 | 98 | 32 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | HSPG2 RELN FBLN5 CD248 LAMA1 LAMA2 LAMA5 LAMC2 BCAN TECTA ELFN2 FREM1 CRELD1 FBLN1 FBN1 FCGBP PHOSPHO1 MEGF6 OTOGL P3H1 ADAMTS20 NID1 PLAT LTBP1 LTBP2 MUC2 VWA2 LTBP4 MUC5AC FBN3 OC90 OTOG | 3.85e-24 | 658 | 98 | 32 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | HSPG2 RELN FBLN5 LAMA1 LAMA2 LAMA5 LAMC2 BCAN FREM1 CRELD1 FBLN1 FBN1 MEGF6 P3H1 ADAMTS20 NID1 PLAT LTBP1 LTBP2 MUC2 VWA2 LTBP4 | 3.74e-15 | 530 | 98 | 22 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | HSPG2 LAMA1 LAMA2 LAMA5 LAMC2 FREM1 FBLN1 FBN1 P3H1 NID1 VWA2 | 1.24e-11 | 122 | 98 | 11 | GO:0005604 |
| GeneOntologyCellularComponent | microfibril | 3.14e-07 | 13 | 98 | 4 | GO:0001527 | |
| GeneOntologyCellularComponent | laminin complex | 1.17e-05 | 10 | 98 | 3 | GO:0043256 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.25e-05 | 109 | 98 | 6 | GO:0005796 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 6.48e-05 | 17 | 98 | 3 | GO:0098637 | |
| GeneOntologyCellularComponent | mucus layer | 6.51e-05 | 3 | 98 | 2 | GO:0070701 | |
| GeneOntologyCellularComponent | laminin-5 complex | 1.30e-04 | 4 | 98 | 2 | GO:0005610 | |
| GeneOntologyCellularComponent | elastic fiber | 2.16e-04 | 5 | 98 | 2 | GO:0071953 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 1.64e-03 | 13 | 98 | 2 | GO:0099535 | |
| GeneOntologyCellularComponent | contractile ring | 1.91e-03 | 14 | 98 | 2 | GO:0070938 | |
| GeneOntologyCellularComponent | dendrite | DHX36 RELN MAP1B LAMA2 BCAN GRM6 LRP2 LTBP1 TACR1 DMWD EPHA10 | 2.26e-03 | 858 | 98 | 11 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | DHX36 RELN MAP1B LAMA2 BCAN GRM6 LRP2 LTBP1 TACR1 DMWD EPHA10 | 2.30e-03 | 860 | 98 | 11 | GO:0097447 |
| GeneOntologyCellularComponent | nuclear inner membrane | 2.69e-03 | 59 | 98 | 3 | GO:0005637 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 2.69e-03 | 59 | 98 | 3 | GO:0098636 | |
| HumanPheno | Multiple bladder diverticula | 5.94e-06 | 5 | 44 | 3 | HP:0012619 | |
| HumanPheno | Emphysema | 1.51e-05 | 64 | 44 | 6 | HP:0002097 | |
| HumanPheno | Peripheral pulmonary artery stenosis | 2.00e-05 | 40 | 44 | 5 | HP:0004969 | |
| HumanPheno | Abnormal cranial suture/fontanelle morphology | TPO HSPG2 FBLN5 MAP1B NSUN2 FREM1 CRELD1 FBN1 P3H1 LRP2 LTBP1 LTBP4 NOTCH2 NOTCH3 | 2.40e-05 | 472 | 44 | 14 | HP:0000235 |
| HumanPheno | Abnormality of cranial sutures | TPO HSPG2 FBLN5 MAP1B NSUN2 FREM1 CRELD1 FBN1 P3H1 LTBP1 NOTCH2 NOTCH3 | 7.21e-05 | 388 | 44 | 12 | HP:0011329 |
| MousePheno | abnormal thoracic aorta morphology | 9.38e-07 | 134 | 80 | 8 | MP:0010468 | |
| MousePheno | abnormal ear morphology | TPO HSPG2 ROR1 LAMA2 LAMA5 LAMC2 TECTA NSUN2 FBLN1 JAG1 LRP2 OC90 OTOG | 2.40e-06 | 470 | 80 | 13 | MP:0002102 |
| MousePheno | hearing/vestibular/ear phenotype | TPO HSPG2 ROR1 LAMA2 LAMA5 LAMC2 TECTA EFHB NSUN2 FBLN1 PPP6C OTOGL JAG1 LRP2 DLEC1 NOTCH3 OC90 OTOG | 2.62e-06 | 905 | 80 | 18 | MP:0005377 |
| MousePheno | abnormal basement membrane morphology | 3.04e-06 | 40 | 80 | 5 | MP:0004272 | |
| MousePheno | abnormal aorta morphology | 5.32e-06 | 225 | 80 | 9 | MP:0000272 | |
| MousePheno | abnormal ascending aorta morphology | 6.73e-06 | 22 | 80 | 4 | MP:0009867 | |
| MousePheno | increased susceptibility to induced thrombosis | 9.69e-06 | 24 | 80 | 4 | MP:0031121 | |
| MousePheno | abnormal blood vessel morphology | HSPG2 FBLN5 LAMA1 LAMA5 PRPH2 NSUN2 CRB1 SEPTIN2 CRELD1 FBLN1 FBN1 PRICKLE3 JAG1 LRP2 PXN NID1 PLAT LTBP1 LTBP4 NOTCH2 NOTCH3 PROS1 | 1.75e-05 | 1472 | 80 | 22 | MP:0001614 |
| MousePheno | abnormal extracellular matrix morphology | 2.26e-05 | 100 | 80 | 6 | MP:0013258 | |
| MousePheno | abnormal thrombosis | 3.14e-05 | 106 | 80 | 6 | MP:0005048 | |
| MousePheno | abnormal tectorial membrane morphology | 3.17e-05 | 32 | 80 | 4 | MP:0003149 | |
| MousePheno | abnormal dermis reticular layer collagen network | 3.23e-05 | 2 | 80 | 2 | MP:0009826 | |
| MousePheno | abnormal artery morphology | HSPG2 FBLN5 LAMA5 NSUN2 FBLN1 FBN1 LRP2 PXN LTBP1 LTBP4 NOTCH3 | 3.93e-05 | 440 | 80 | 11 | MP:0002191 |
| MousePheno | abnormal skin morphology | RELN FBLN5 KCNH8 CD248 LAMA5 LAMC2 NSUN2 FREM1 FBLN1 FBN1 OTOGL P3H1 JAG1 SHPRH ADAMTS20 LTBP4 ALK CNOT4 NOTCH2 PROS1 SPINK5 | 4.84e-05 | 1455 | 80 | 21 | MP:0002060 |
| MousePheno | decreased bone trabecula number | 4.89e-05 | 70 | 80 | 5 | MP:0010869 | |
| MousePheno | abnormal inner ear morphology | 5.64e-05 | 303 | 80 | 9 | MP:0000026 | |
| MousePheno | overexpanded pulmonary alveolus | 5.69e-05 | 37 | 80 | 4 | MP:0001183 | |
| MousePheno | emphysema | 5.69e-05 | 37 | 80 | 4 | MP:0001958 | |
| MousePheno | abnormal systemic artery morphology | 5.79e-05 | 304 | 80 | 9 | MP:0011655 | |
| MousePheno | abnormal cochlear labyrinth morphology | 5.79e-05 | 235 | 80 | 8 | MP:0004426 | |
| MousePheno | abnormal scala media morphology | 5.79e-05 | 235 | 80 | 8 | MP:0003169 | |
| MousePheno | abnormal aortic arch morphology | 6.03e-05 | 119 | 80 | 6 | MP:0004113 | |
| MousePheno | abnormal aorta elastic fiber morphology | 6.28e-05 | 14 | 80 | 3 | MP:0003211 | |
| MousePheno | abnormal cochlea morphology | 8.45e-05 | 248 | 80 | 8 | MP:0000031 | |
| MousePheno | abnormal ascending aorta and coronary artery attachment | 9.67e-05 | 3 | 80 | 2 | MP:0010472 | |
| MousePheno | abnormal bone trabecula morphology | 1.17e-04 | 134 | 80 | 6 | MP:0010867 | |
| MousePheno | abnormal membranous labyrinth morphology | 1.24e-04 | 262 | 80 | 8 | MP:0000035 | |
| MousePheno | short snout | 1.26e-04 | 136 | 80 | 6 | MP:0000445 | |
| MousePheno | retina spots | 1.64e-04 | 19 | 80 | 3 | MP:0012671 | |
| MousePheno | abnormal cardiovascular development | HSPG2 FBLN5 LAMA5 NSUN2 CRELD1 THBD FBLN1 JAG1 LRP2 PXN PLAT LTBP1 NOTCH3 PROS1 | 1.64e-04 | 802 | 80 | 14 | MP:0002925 |
| MousePheno | small snout | 1.73e-04 | 144 | 80 | 6 | MP:0030190 | |
| MousePheno | abnormal Muller cell morphology | 1.92e-04 | 20 | 80 | 3 | MP:0005547 | |
| MousePheno | abnormal sperm individualization | 1.93e-04 | 4 | 80 | 2 | MP:0031372 | |
| MousePheno | abnormal dermis reticular layer morphology | 1.93e-04 | 4 | 80 | 2 | MP:0005081 | |
| MousePheno | abnormal glomerular capillary endothelium morphology | 2.23e-04 | 21 | 80 | 3 | MP:0011453 | |
| MousePheno | abnormal susceptibility to induced thrombosis | 2.35e-04 | 53 | 80 | 4 | MP:0020408 | |
| MousePheno | abnormal aorta elastic tissue morphology | 2.57e-04 | 22 | 80 | 3 | MP:0009862 | |
| MousePheno | decreased bone volume | 2.66e-04 | 100 | 80 | 5 | MP:0010876 | |
| MousePheno | intracranial hemorrhage | 3.20e-04 | 104 | 80 | 5 | MP:0001915 | |
| MousePheno | abnormal breathing pattern | 3.33e-04 | 303 | 80 | 8 | MP:0001951 | |
| MousePheno | abnormal blood vessel elastic tissue morphology | 3.35e-04 | 24 | 80 | 3 | MP:0006083 | |
| MousePheno | blistering | 3.35e-04 | 24 | 80 | 3 | MP:0001208 | |
| MousePheno | decreased trabecular bone volume | 3.80e-04 | 60 | 80 | 4 | MP:0010879 | |
| MousePheno | increased or absent threshold for auditory brainstem response | 3.99e-04 | 236 | 80 | 7 | MP:0011967 | |
| MousePheno | abnormal auditory brainstem response | TPO ROR1 LAMA2 TECTA EFHB PPP6C OTOGL LRP2 DLEC1 NOTCH3 OTOG | 4.19e-04 | 576 | 80 | 11 | MP:0004738 |
| MousePheno | abnormal basal lamina morphology | 4.78e-04 | 6 | 80 | 2 | MP:0004273 | |
| MousePheno | bowed humerus | 4.78e-04 | 6 | 80 | 2 | MP:0004373 | |
| MousePheno | abnormal ear physiology | TPO ROR1 LAMA2 LAMC2 TECTA EFHB PPP6C OTOGL LRP2 DLEC1 NOTCH3 OTOG | 4.84e-04 | 684 | 80 | 12 | MP:0003878 |
| MousePheno | abnormal hearing electrophysiology | TPO ROR1 LAMA2 TECTA EFHB PPP6C OTOGL LRP2 DLEC1 NOTCH3 OTOG | 5.42e-04 | 594 | 80 | 11 | MP:0006335 |
| MousePheno | abnormal forelimb morphology | 6.07e-04 | 182 | 80 | 6 | MP:0000550 | |
| MousePheno | abnormal eye physiology | RELN MAP1B LAMA1 PRPH2 GRM6 NSUN2 CRB1 FBLN1 PRICKLE3 PLAT MUC5AC | 6.40e-04 | 606 | 80 | 11 | MP:0005253 |
| MousePheno | limbs/digits/tail phenotype | TPO HSPG2 MAP1B LAMA5 LAMC2 NSUN2 FREM1 FZD7 FBN1 SCUBE2 PHOSPHO1 PPP6C P3H1 LRP2 ADAMTS20 LTBP1 NOTCH2 | 6.42e-04 | 1258 | 80 | 17 | MP:0005371 |
| MousePheno | abnormal limb morphology | TPO HSPG2 MAP1B LAMA5 LAMC2 NSUN2 FREM1 FBN1 SCUBE2 PHOSPHO1 PPP6C P3H1 ADAMTS20 LTBP1 NOTCH2 | 6.43e-04 | 1028 | 80 | 15 | MP:0002109 |
| MousePheno | abnormal pulmonary circulation | 6.48e-04 | 69 | 80 | 4 | MP:0002295 | |
| MousePheno | abnormal otolith morphology | 6.56e-04 | 30 | 80 | 3 | MP:0002894 | |
| MousePheno | abnormal snout morphology | 6.63e-04 | 257 | 80 | 7 | MP:0000443 | |
| MousePheno | abnormal compact bone thickness | 6.65e-04 | 122 | 80 | 5 | MP:0000134 | |
| MousePheno | abnormal retina inner nuclear layer morphology | 6.65e-04 | 122 | 80 | 5 | MP:0003733 | |
| MousePheno | abnormal skin tensile strength | 7.94e-04 | 32 | 80 | 3 | MP:0005275 | |
| MousePheno | abnormal otolithic membrane morphology | 7.94e-04 | 32 | 80 | 3 | MP:0002895 | |
| MousePheno | short femur | 7.98e-04 | 127 | 80 | 5 | MP:0003109 | |
| MousePheno | absent vestibular hair cells | 8.86e-04 | 8 | 80 | 2 | MP:0004325 | |
| MousePheno | decreased femur size | 8.86e-04 | 130 | 80 | 5 | MP:0030825 | |
| MousePheno | abnormal skeleton physiology | HSPG2 LAMA2 FREM1 FBN1 SCUBE2 PHOSPHO1 P3H1 PLAT TACR1 NOTCH2 NOTCH3 | 9.05e-04 | 632 | 80 | 11 | MP:0001533 |
| MousePheno | abnormal vascular development | 1.01e-03 | 542 | 80 | 10 | MP:0000259 | |
| MousePheno | abnormal cardiac outflow tract development | 1.02e-03 | 134 | 80 | 5 | MP:0006126 | |
| MousePheno | aneurysm | 1.04e-03 | 35 | 80 | 3 | MP:0003279 | |
| MousePheno | vascular ring | 1.04e-03 | 35 | 80 | 3 | MP:0010466 | |
| MousePheno | abnormal hearing physiology | TPO ROR1 LAMA2 TECTA EFHB PPP6C OTOGL LRP2 DLEC1 NOTCH3 OTOG | 1.04e-03 | 643 | 80 | 11 | MP:0001963 |
| MousePheno | abnormal vestibular labyrinth morphology | 1.13e-03 | 80 | 80 | 4 | MP:0004427 | |
| MousePheno | increased aorta wall thickness | 1.13e-03 | 9 | 80 | 2 | MP:0010996 | |
| MousePheno | enlarged otoliths | 1.13e-03 | 9 | 80 | 2 | MP:0003143 | |
| MousePheno | abnormal distortion product otoacoustic emission amplitude | 1.13e-03 | 9 | 80 | 2 | MP:0014408 | |
| MousePheno | decreased distortion product otoacoustic emission amplitude | 1.13e-03 | 9 | 80 | 2 | MP:0014409 | |
| MousePheno | abnormal inner ear vestibule morphology | 1.18e-03 | 81 | 80 | 4 | MP:0000034 | |
| MousePheno | abnormal aortic arch and aortic arch branch attachment | 1.22e-03 | 37 | 80 | 3 | MP:0010464 | |
| MousePheno | decreased compact bone thickness | 1.30e-03 | 83 | 80 | 4 | MP:0000135 | |
| MousePheno | abnormal trabecular bone morphology | 1.32e-03 | 289 | 80 | 7 | MP:0000130 | |
| MousePheno | abnormal truncus arteriosus septation | 1.36e-03 | 84 | 80 | 4 | MP:0010454 | |
| MousePheno | abnormal muscle morphology | HSPG2 LAMA2 NSUN2 ZNF416 FREM1 FBLN1 FBN1 P3H1 LRP2 PLAT LTBP1 LTBP4 NOTCH2 NOTCH3 PROS1 | 1.36e-03 | 1106 | 80 | 15 | MP:0002108 |
| MousePheno | abnormal femur morphology | 1.41e-03 | 214 | 80 | 6 | MP:0000559 | |
| MousePheno | impaired behavioral response to morphine | 1.41e-03 | 10 | 80 | 2 | MP:0009757 | |
| MousePheno | abnormal chest morphology | 1.42e-03 | 39 | 80 | 3 | MP:0004134 | |
| MousePheno | abnormal aorta tunica media morphology | 1.42e-03 | 39 | 80 | 3 | MP:0009873 | |
| MousePheno | abnormal hindlimb stylopod morphology | 1.44e-03 | 215 | 80 | 6 | MP:0003856 | |
| MousePheno | abnormal limb long bone morphology | TPO HSPG2 NSUN2 FBN1 SCUBE2 PHOSPHO1 PPP6C P3H1 LTBP1 NOTCH2 | 1.44e-03 | 568 | 80 | 10 | MP:0011504 |
| MousePheno | abnormal right subclavian artery morphology | 1.53e-03 | 40 | 80 | 3 | MP:0010487 | |
| MousePheno | abnormal long bone morphology | TPO HSPG2 NSUN2 FBN1 SCUBE2 PHOSPHO1 PPP6C P3H1 LTBP1 ALK NOTCH2 | 1.56e-03 | 676 | 80 | 11 | MP:0003723 |
| MousePheno | abnormal utricle morphology | 1.65e-03 | 41 | 80 | 3 | MP:0006090 | |
| MousePheno | impaired basement membrane formation | 1.72e-03 | 11 | 80 | 2 | MP:0003044 | |
| MousePheno | absent neurocranium | 1.72e-03 | 11 | 80 | 2 | MP:0000075 | |
| MousePheno | abnormal chondrocyte physiology | 1.76e-03 | 42 | 80 | 3 | MP:0009780 | |
| MousePheno | heart right ventricle hypertrophy | 1.76e-03 | 42 | 80 | 3 | MP:0000276 | |
| MousePheno | abnormal limb bone morphology | TPO HSPG2 NSUN2 FBN1 SCUBE2 PHOSPHO1 PPP6C P3H1 LTBP1 NOTCH2 | 1.84e-03 | 587 | 80 | 10 | MP:0002115 |
| MousePheno | abnormal cartilage physiology | 1.89e-03 | 43 | 80 | 3 | MP:0031306 | |
| MousePheno | abnormal respiratory system morphology | HSPG2 FBLN5 ROR1 LAMA5 NSUN2 FREM1 THBD FBLN1 FBN1 LRP2 C1R PLAT TACR1 LTBP4 | 1.91e-03 | 1027 | 80 | 14 | MP:0002132 |
| MousePheno | abnormal capillary morphology | 1.97e-03 | 93 | 80 | 4 | MP:0003658 | |
| MousePheno | abnormal respiratory function | 1.98e-03 | 399 | 80 | 8 | MP:0002327 | |
| MousePheno | abnormal epidermal-dermal junction morphology | 2.06e-03 | 12 | 80 | 2 | MP:0011159 | |
| MousePheno | abnormal inner ear development | 2.06e-03 | 12 | 80 | 2 | MP:0011238 | |
| Domain | EGF-like_dom | TPO HSPG2 RELN FBLN5 CD248 LAMA1 LAMA2 LAMA5 LAMC2 BCAN TECTA LRP1B CRB1 CRELD1 THBD FBLN1 FBN1 FCGBP SCUBE2 MEGF6 JAG1 LRP2 C1R NID1 PLAT LTBP1 LTBP2 VWA2 LTBP4 FBN3 NOTCH2 NOTCH3 OTOG PROS1 | 5.93e-40 | 249 | 95 | 34 | IPR000742 |
| Domain | EGF | TPO HSPG2 RELN FBLN5 CD248 LAMA1 LAMA2 LAMA5 LAMC2 BCAN TECTA LRP1B CRB1 CRELD1 THBD FBLN1 FBN1 FCGBP SCUBE2 MEGF6 JAG1 LRP2 C1R NID1 PLAT LTBP1 LTBP2 VWA2 LTBP4 FBN3 NOTCH2 NOTCH3 PROS1 | 3.74e-39 | 235 | 95 | 33 | SM00181 |
| Domain | EGF-like_CS | TPO HSPG2 RELN FBLN5 CD248 LAMA1 LAMA2 LAMA5 LAMC2 BCAN LRP1B CRB1 CRELD1 THBD FBLN1 FBN1 SCUBE2 MEGF6 JAG1 LRP2 C1R NID1 PLAT LTBP1 LTBP2 VWA2 LTBP4 FBN3 EPHA10 NOTCH2 NOTCH3 PROS1 | 5.89e-36 | 261 | 95 | 32 | IPR013032 |
| Domain | EGF_2 | TPO HSPG2 RELN FBLN5 CD248 LAMA1 LAMA2 LAMA5 LAMC2 BCAN LRP1B CRB1 CRELD1 THBD FBLN1 FBN1 SCUBE2 MEGF6 JAG1 LRP2 C1R NID1 PLAT LTBP1 LTBP2 VWA2 LTBP4 FBN3 EPHA10 NOTCH2 NOTCH3 PROS1 | 9.75e-36 | 265 | 95 | 32 | PS01186 |
| Domain | EGF_1 | TPO HSPG2 RELN FBLN5 CD248 LAMA1 LAMA2 LAMA5 LAMC2 BCAN LRP1B CRB1 CRELD1 THBD FBLN1 FBN1 SCUBE2 MEGF6 JAG1 LRP2 C1R NID1 PLAT LTBP1 LTBP2 VWA2 LTBP4 FBN3 NOTCH2 NOTCH3 PROS1 | 1.12e-34 | 255 | 95 | 31 | PS00022 |
| Domain | EGF_CA | TPO HSPG2 FBLN5 CD248 LRP1B CRB1 CRELD1 THBD FBLN1 FBN1 SCUBE2 MEGF6 JAG1 LRP2 C1R NID1 LTBP1 LTBP2 VWA2 LTBP4 FBN3 NOTCH2 NOTCH3 PROS1 | 4.48e-32 | 122 | 95 | 24 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | TPO HSPG2 FBLN5 CD248 LRP1B CRB1 CRELD1 THBD FBLN1 FBN1 SCUBE2 MEGF6 JAG1 LRP2 C1R NID1 LTBP1 LTBP2 VWA2 LTBP4 FBN3 NOTCH2 NOTCH3 PROS1 | 6.84e-32 | 124 | 95 | 24 | IPR001881 |
| Domain | EGF_3 | TPO HSPG2 RELN FBLN5 CD248 BCAN LRP1B CRB1 CRELD1 THBD FBLN1 FBN1 SCUBE2 MEGF6 JAG1 LRP2 C1R NID1 PLAT LTBP1 LTBP2 VWA2 LTBP4 FBN3 NOTCH2 NOTCH3 OTOG PROS1 | 5.35e-31 | 235 | 95 | 28 | PS50026 |
| Domain | EGF_Ca-bd_CS | TPO FBLN5 CD248 LRP1B CRB1 CRELD1 THBD FBLN1 FBN1 SCUBE2 MEGF6 JAG1 LRP2 C1R NID1 LTBP1 LTBP2 LTBP4 FBN3 NOTCH2 NOTCH3 PROS1 | 6.54e-31 | 97 | 95 | 22 | IPR018097 |
| Domain | EGF_CA | TPO FBLN5 CD248 LRP1B CRB1 CRELD1 THBD FBLN1 FBN1 SCUBE2 MEGF6 JAG1 LRP2 C1R NID1 LTBP1 LTBP2 LTBP4 FBN3 NOTCH2 NOTCH3 PROS1 | 1.08e-30 | 99 | 95 | 22 | PS01187 |
| Domain | EGF_CA | TPO FBLN5 CD248 LRP1B CRELD1 THBD FBLN1 FBN1 SCUBE2 MEGF6 JAG1 LRP2 C1R NID1 LTBP1 LTBP2 LTBP4 FBN3 NOTCH2 NOTCH3 PROS1 | 2.85e-30 | 86 | 95 | 21 | PF07645 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | TPO FBLN5 CD248 LRP1B CRB1 CRELD1 THBD FBLN1 FBN1 SCUBE2 MEGF6 JAG1 LRP2 C1R NID1 LTBP1 LTBP2 LTBP4 FBN3 NOTCH2 NOTCH3 PROS1 | 5.64e-30 | 106 | 95 | 22 | IPR000152 |
| Domain | Growth_fac_rcpt_ | HSPG2 FBLN5 CD248 LAMA1 LAMA5 LAMC2 LRP1B CRB1 CRELD1 THBD FBLN1 FBN1 SCUBE2 MEGF6 JAG1 LRP2 NID1 LTBP1 LTBP2 LTBP4 FBN3 NOTCH2 NOTCH3 PROS1 | 2.52e-29 | 156 | 95 | 24 | IPR009030 |
| Domain | ASX_HYDROXYL | TPO FBLN5 LRP1B CRB1 CRELD1 THBD FBLN1 FBN1 SCUBE2 MEGF6 JAG1 LRP2 C1R NID1 LTBP1 LTBP2 LTBP4 FBN3 NOTCH2 NOTCH3 PROS1 | 9.59e-29 | 100 | 95 | 21 | PS00010 |
| Domain | EGF | HSPG2 CD248 BCAN TECTA LRP1B CRB1 THBD SCUBE2 MEGF6 JAG1 LRP2 NID1 PLAT LTBP1 LTBP2 VWA2 FBN3 NOTCH2 NOTCH3 PROS1 | 8.92e-25 | 126 | 95 | 20 | PF00008 |
| Domain | cEGF | 3.54e-17 | 26 | 95 | 10 | IPR026823 | |
| Domain | cEGF | 3.54e-17 | 26 | 95 | 10 | PF12662 | |
| Domain | TIL_dom | 2.34e-13 | 14 | 95 | 7 | IPR002919 | |
| Domain | VWC_out | 3.37e-12 | 19 | 95 | 7 | SM00215 | |
| Domain | TIL | 1.33e-11 | 12 | 95 | 6 | PF01826 | |
| Domain | C8 | 1.33e-11 | 12 | 95 | 6 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 2.46e-11 | 13 | 95 | 6 | IPR014853 | |
| Domain | C8 | 2.46e-11 | 13 | 95 | 6 | SM00832 | |
| Domain | TB | 6.38e-11 | 7 | 95 | 5 | PF00683 | |
| Domain | VWD | 1.13e-10 | 16 | 95 | 6 | SM00216 | |
| Domain | VWF_type-D | 1.13e-10 | 16 | 95 | 6 | IPR001846 | |
| Domain | VWFD | 1.13e-10 | 16 | 95 | 6 | PS51233 | |
| Domain | VWD | 1.13e-10 | 16 | 95 | 6 | PF00094 | |
| Domain | LAMININ_IVA | 1.69e-10 | 8 | 95 | 5 | PS51115 | |
| Domain | Laminin_B | 1.69e-10 | 8 | 95 | 5 | PF00052 | |
| Domain | - | 1.69e-10 | 8 | 95 | 5 | 3.90.290.10 | |
| Domain | LamB | 1.69e-10 | 8 | 95 | 5 | SM00281 | |
| Domain | Laminin_IV | 1.69e-10 | 8 | 95 | 5 | IPR000034 | |
| Domain | TB | 3.80e-10 | 9 | 95 | 5 | PS51364 | |
| Domain | TB_dom | 3.80e-10 | 9 | 95 | 5 | IPR017878 | |
| Domain | Laminin_EGF | 4.21e-10 | 35 | 95 | 7 | PF00053 | |
| Domain | Laminin_EGF | 7.81e-10 | 38 | 95 | 7 | IPR002049 | |
| Domain | VWF_dom | 1.64e-09 | 42 | 95 | 7 | IPR001007 | |
| Domain | hEGF | 5.08e-09 | 28 | 95 | 6 | PF12661 | |
| Domain | EGF_Lam | 2.13e-08 | 35 | 95 | 6 | SM00180 | |
| Domain | EGF_extracell | 2.18e-08 | 60 | 95 | 7 | IPR013111 | |
| Domain | EGF_2 | 2.18e-08 | 60 | 95 | 7 | PF07974 | |
| Domain | VWC | 3.57e-08 | 38 | 95 | 6 | SM00214 | |
| Domain | LAM_G_DOMAIN | 3.57e-08 | 38 | 95 | 6 | PS50025 | |
| Domain | Laminin_G_2 | 4.93e-08 | 40 | 95 | 6 | PF02210 | |
| Domain | LamG | 8.92e-08 | 44 | 95 | 6 | SM00282 | |
| Domain | Laminin_G_1 | 2.02e-07 | 11 | 95 | 4 | PF00054 | |
| Domain | EGF_LAM_2 | 3.94e-07 | 30 | 95 | 5 | PS50027 | |
| Domain | EGF_LAM_1 | 3.94e-07 | 30 | 95 | 5 | PS01248 | |
| Domain | Laminin_G | 4.83e-07 | 58 | 95 | 6 | IPR001791 | |
| Domain | Laminin_aI | 1.27e-06 | 5 | 95 | 3 | IPR009254 | |
| Domain | Laminin_I | 1.27e-06 | 5 | 95 | 3 | PF06008 | |
| Domain | Laminin_II | 1.27e-06 | 5 | 95 | 3 | PF06009 | |
| Domain | Laminin_domII | 1.27e-06 | 5 | 95 | 3 | IPR010307 | |
| Domain | CT | 4.28e-06 | 22 | 95 | 4 | SM00041 | |
| Domain | Cys_knot_C | 7.32e-06 | 25 | 95 | 4 | IPR006207 | |
| Domain | CTCK_2 | 7.32e-06 | 25 | 95 | 4 | PS01225 | |
| Domain | - | 8.91e-06 | 95 | 95 | 6 | 2.60.120.200 | |
| Domain | ConA-like_dom | 1.59e-05 | 219 | 95 | 8 | IPR013320 | |
| Domain | VWFC_2 | 4.06e-05 | 38 | 95 | 4 | PS50184 | |
| Domain | Ldl_recept_b | 4.46e-05 | 14 | 95 | 3 | PF00058 | |
| Domain | LDLRB | 4.46e-05 | 14 | 95 | 3 | PS51120 | |
| Domain | LY | 5.55e-05 | 15 | 95 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 5.55e-05 | 15 | 95 | 3 | IPR000033 | |
| Domain | Laminin_N | 6.80e-05 | 16 | 95 | 3 | IPR008211 | |
| Domain | LAMININ_NTER | 6.80e-05 | 16 | 95 | 3 | PS51117 | |
| Domain | Laminin_N | 6.80e-05 | 16 | 95 | 3 | PF00055 | |
| Domain | LamNT | 6.80e-05 | 16 | 95 | 3 | SM00136 | |
| Domain | TILa | 7.65e-05 | 3 | 95 | 2 | PF12714 | |
| Domain | K_chnl_volt-dep_ELK | 7.65e-05 | 3 | 95 | 2 | IPR003950 | |
| Domain | TILa_dom | 7.65e-05 | 3 | 95 | 2 | IPR025615 | |
| Domain | DUF3454 | 7.65e-05 | 3 | 95 | 2 | PF11936 | |
| Domain | DUF3454_notch | 7.65e-05 | 3 | 95 | 2 | IPR024600 | |
| Domain | DUF3454 | 7.65e-05 | 3 | 95 | 2 | SM01334 | |
| Domain | FBN | 7.65e-05 | 3 | 95 | 2 | IPR011398 | |
| Domain | - | 8.70e-05 | 46 | 95 | 4 | 4.10.400.10 | |
| Domain | CTCK_1 | 9.84e-05 | 18 | 95 | 3 | PS01185 | |
| Domain | LDLRA_1 | 1.03e-04 | 48 | 95 | 4 | PS01209 | |
| Domain | LDLRA_2 | 1.12e-04 | 49 | 95 | 4 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 1.12e-04 | 49 | 95 | 4 | IPR002172 | |
| Domain | LDLa | 1.12e-04 | 49 | 95 | 4 | SM00192 | |
| Domain | Notch | 1.53e-04 | 4 | 95 | 2 | IPR008297 | |
| Domain | NODP | 1.53e-04 | 4 | 95 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 1.53e-04 | 4 | 95 | 2 | IPR011656 | |
| Domain | Dpy19 | 1.53e-04 | 4 | 95 | 2 | PF10034 | |
| Domain | Notch_NOD_dom | 1.53e-04 | 4 | 95 | 2 | IPR010660 | |
| Domain | NOD | 1.53e-04 | 4 | 95 | 2 | PF06816 | |
| Domain | Dpy-19/Dpy-19-like | 1.53e-04 | 4 | 95 | 2 | IPR018732 | |
| Domain | NOD | 1.53e-04 | 4 | 95 | 2 | SM01338 | |
| Domain | NODP | 1.53e-04 | 4 | 95 | 2 | SM01339 | |
| Domain | SUSHI | 1.88e-04 | 56 | 95 | 4 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 2.02e-04 | 57 | 95 | 4 | IPR000436 | |
| Domain | NIDO_dom | 2.53e-04 | 5 | 95 | 2 | IPR003886 | |
| Domain | NIDO | 2.53e-04 | 5 | 95 | 2 | SM00539 | |
| Domain | NIDO | 2.53e-04 | 5 | 95 | 2 | PF06119 | |
| Domain | LNR | 2.53e-04 | 5 | 95 | 2 | PS50258 | |
| Domain | NIDO | 2.53e-04 | 5 | 95 | 2 | PS51220 | |
| Domain | WxxW_domain | 3.79e-04 | 6 | 95 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 3.79e-04 | 6 | 95 | 2 | PF13330 | |
| Domain | Notch_dom | 5.29e-04 | 7 | 95 | 2 | IPR000800 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | HSPG2 FBLN5 LAMA1 LAMA2 LAMA5 LAMC2 BCAN FBLN1 FBN1 P3H1 NID1 LTBP1 LTBP2 LTBP4 FBN3 | 5.19e-11 | 300 | 76 | 15 | M610 |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 9.03e-10 | 37 | 76 | 7 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.26e-09 | 44 | 76 | 7 | M26969 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.08e-08 | 30 | 76 | 6 | M27216 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 2.50e-07 | 11 | 76 | 4 | M158 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 7.16e-07 | 32 | 76 | 5 | MM14854 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.41e-06 | 66 | 76 | 6 | M18 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.99e-06 | 39 | 76 | 5 | MM14601 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 5.85e-06 | 84 | 76 | 6 | M7098 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 8.27e-06 | 8 | 76 | 3 | M47850 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 9.06e-06 | 25 | 76 | 4 | M39713 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.01e-05 | 140 | 76 | 7 | M587 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.59e-05 | 59 | 76 | 5 | M27218 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.92e-05 | 30 | 76 | 4 | M27772 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 2.83e-05 | 33 | 76 | 4 | M39503 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 3.20e-05 | 12 | 76 | 3 | M47532 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 4.14e-05 | 13 | 76 | 3 | M47423 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 5.01e-05 | 38 | 76 | 4 | MM14874 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.46e-05 | 76 | 76 | 5 | M27219 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 6.58e-05 | 79 | 76 | 5 | M27643 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 6.79e-05 | 41 | 76 | 4 | M27778 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 7.27e-05 | 258 | 76 | 8 | MM14572 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.07e-04 | 46 | 76 | 4 | M239 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.17e-04 | 47 | 76 | 4 | M646 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.20e-04 | 143 | 76 | 6 | M27275 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.87e-04 | 21 | 76 | 3 | MM15706 | |
| Pathway | WP_COMPLEMENT_AND_COAGULATION_CASCADES | 2.65e-04 | 58 | 76 | 4 | M39649 | |
| Pathway | WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES | 2.84e-04 | 59 | 76 | 4 | M48343 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 2.84e-04 | 5 | 76 | 2 | M27411 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 4.01e-04 | 27 | 76 | 3 | M39545 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 4.24e-04 | 6 | 76 | 2 | M27068 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 4.37e-04 | 66 | 76 | 4 | MM15925 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 4.89e-04 | 68 | 76 | 4 | M27303 | |
| Pathway | WP_FOCAL_ADHESION | 5.09e-04 | 187 | 76 | 6 | MM15913 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 5.17e-04 | 69 | 76 | 4 | M16894 | |
| Pathway | WP_FOCAL_ADHESION | 7.06e-04 | 199 | 76 | 6 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 7.06e-04 | 199 | 76 | 6 | M7253 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 7.84e-04 | 77 | 76 | 4 | MM14670 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 1.09e-03 | 84 | 76 | 4 | M3228 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 1.53e-03 | 11 | 76 | 2 | M47865 | |
| Pathway | WP_CANCER_PATHWAYS | 1.57e-03 | 507 | 76 | 9 | M48302 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.65e-03 | 94 | 76 | 4 | M1041 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 1.78e-03 | 96 | 76 | 4 | M39834 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.82e-03 | 45 | 76 | 3 | M39571 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.83e-03 | 12 | 76 | 2 | M47533 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.94e-03 | 46 | 76 | 3 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 2.06e-03 | 47 | 76 | 3 | M7946 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 2.15e-03 | 13 | 76 | 2 | M47534 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.18e-03 | 532 | 76 | 9 | M27870 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 2.27e-03 | 250 | 76 | 6 | M27554 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.83e-03 | 109 | 76 | 4 | MM15164 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.88e-03 | 15 | 76 | 2 | MM14922 | |
| Pubmed | HSPG2 FBLN5 LAMA1 LAMA2 LAMA5 LAMC2 FREM1 FBLN1 FBN1 NID1 LTBP1 LTBP2 MUC2 LTBP4 | 4.58e-17 | 167 | 98 | 14 | 22159717 | |
| Pubmed | HSPG2 RELN FBLN5 LAMA1 LAMA2 LAMA5 CRELD1 FBN1 MEGF6 NID1 LTBP1 LTBP2 LTBP4 | 3.13e-15 | 175 | 98 | 13 | 28071719 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | HSPG2 FBLN5 LAMA2 LAMA5 LAMC2 CRELD1 FBLN1 FBN1 NID1 LTBP1 LTBP4 | 1.67e-13 | 135 | 98 | 11 | 28675934 |
| Pubmed | HSPG2 FBLN5 LAMA2 LAMA5 LAMC2 FBLN1 FBN1 NID1 LTBP1 MUC2 LTBP4 | 6.69e-13 | 153 | 98 | 11 | 25037231 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 1.34e-12 | 79 | 98 | 9 | 18757743 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 2.10e-12 | 15 | 98 | 6 | 15895400 | |
| Pubmed | 1.27e-11 | 146 | 98 | 10 | 27068509 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 1.30e-11 | 101 | 98 | 9 | 20551380 | |
| Pubmed | 1.25e-10 | 12 | 98 | 5 | 16750824 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | HSPG2 FBLN5 LAMA1 LAMA2 FBLN1 FBN1 NID1 LTBP1 LTBP2 LTBP4 PROS1 | 1.26e-10 | 248 | 98 | 11 | 24006456 |
| Pubmed | 1.93e-10 | 29 | 98 | 6 | 22613833 | ||
| Pubmed | 2.03e-10 | 13 | 98 | 5 | 12682087 | ||
| Pubmed | 2.96e-10 | 5 | 98 | 4 | 11829758 | ||
| Pubmed | 2.98e-10 | 31 | 98 | 6 | 22274697 | ||
| Pubmed | 8.85e-10 | 6 | 98 | 4 | 19349279 | ||
| Pubmed | 1.33e-09 | 18 | 98 | 5 | 14730302 | ||
| Pubmed | 4.11e-09 | 8 | 98 | 4 | 8872465 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | DHX36 HSPG2 FBLN5 MAP1B DPY19L1 LAMA1 LAMA5 LRP1B CRELD1 FBLN1 FBN1 P3H1 NID1 LTBP1 LTBP2 NOTCH2 NOTCH3 PROS1 | 6.49e-09 | 1201 | 98 | 18 | 35696571 |
| Pubmed | 7.39e-09 | 9 | 98 | 4 | 12122015 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 1.01e-08 | 26 | 98 | 5 | 34189436 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.18e-08 | 97 | 98 | 7 | 27559042 | |
| Pubmed | 1.23e-08 | 10 | 98 | 4 | 11784026 | ||
| Pubmed | Primary cellular meningeal defects cause neocortical dysplasia and dyslamination. | 1.23e-08 | 10 | 98 | 4 | 20976766 | |
| Pubmed | 1.23e-08 | 10 | 98 | 4 | 9034910 | ||
| Pubmed | Generation of a conditionally null allele of the laminin alpha1 gene. | 1.23e-08 | 10 | 98 | 4 | 16100707 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 1.93e-08 | 11 | 98 | 4 | 23472759 | |
| Pubmed | 1.93e-08 | 11 | 98 | 4 | 12051813 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 1.93e-08 | 11 | 98 | 4 | 21524702 | |
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 8354280 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 17293099 | ||
| Pubmed | 2.88e-08 | 12 | 98 | 4 | 9396756 | ||
| Pubmed | Large-scale identification of genes implicated in kidney glomerulus development and function. | 4.18e-08 | 34 | 98 | 5 | 16498405 | |
| Pubmed | 5.29e-08 | 71 | 98 | 6 | 33541421 | ||
| Pubmed | 5.81e-08 | 14 | 98 | 4 | 19783738 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | FBLN5 SH3GL3 LAMA5 SEPTIN2 CRELD1 FBLN1 FBN1 MEGF6 LTBP1 LTBP4 NOTCH2 NOTCH3 | 6.25e-08 | 560 | 98 | 12 | 21653829 |
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 7.90e-08 | 15 | 98 | 4 | 12921739 | |
| Pubmed | 7.90e-08 | 15 | 98 | 4 | 10625553 | ||
| Pubmed | 7.90e-08 | 15 | 98 | 4 | 9264260 | ||
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 15611103 | ||
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 10551863 | ||
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 22691042 | ||
| Pubmed | The latent transforming growth factor beta binding protein (LTBP) family. | 8.66e-08 | 4 | 98 | 3 | 11104663 | |
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 12429738 | ||
| Pubmed | Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. | 1.05e-07 | 16 | 98 | 4 | 17948866 | |
| Pubmed | 1.05e-07 | 16 | 98 | 4 | 11564885 | ||
| Pubmed | 1.05e-07 | 16 | 98 | 4 | 17601529 | ||
| Pubmed | 1.11e-07 | 41 | 98 | 5 | 22675208 | ||
| Pubmed | 1.37e-07 | 17 | 98 | 4 | 21983115 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 1.68e-07 | 86 | 98 | 6 | 28327460 | |
| Pubmed | 1.76e-07 | 18 | 98 | 4 | 11311202 | ||
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 11969289 | ||
| Pubmed | Differential expression of five laminin alpha (1-5) chains in developing and adult mouse kidney. | 2.16e-07 | 5 | 98 | 3 | 9415429 | |
| Pubmed | Differential expression of laminin alpha chains during murine tooth development. | 2.16e-07 | 5 | 98 | 3 | 9389447 | |
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 9719032 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 2.16e-07 | 5 | 98 | 3 | 15064243 | |
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 15882997 | ||
| Pubmed | Laminin alpha 2 chain (M chain) is found within the pathway of avian and murine retinal projections. | 2.16e-07 | 5 | 98 | 3 | 8613743 | |
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 11733994 | ||
| Pubmed | 2.77e-07 | 20 | 98 | 4 | 22911573 | ||
| Pubmed | 3.07e-07 | 50 | 98 | 5 | 23658023 | ||
| Pubmed | 3.42e-07 | 21 | 98 | 4 | 27856617 | ||
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 1678389 | ||
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 19110483 | ||
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 9597096 | ||
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 4.31e-07 | 6 | 98 | 3 | 12244553 | |
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 15668394 | ||
| Pubmed | Tropoelastin binding to fibulins, nidogen-2 and other extracellular matrix proteins. | 4.31e-07 | 6 | 98 | 3 | 10544250 | |
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 26555376 | ||
| Pubmed | Effect of basement membrane entactin on epidermal cell attachment and growth. | 4.31e-07 | 6 | 98 | 3 | 3794389 | |
| Pubmed | Laminin-nidogen complex. Extraction with chelating agents and structural characterization. | 4.31e-07 | 6 | 98 | 3 | 3109910 | |
| Pubmed | Structural elucidation of full-length nidogen and the laminin-nidogen complex in solution. | 4.31e-07 | 6 | 98 | 3 | 23948589 | |
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 2119632 | ||
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 22526456 | ||
| Pubmed | Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura. | 4.31e-07 | 6 | 98 | 3 | 19603167 | |
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 9108364 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 4.38e-07 | 101 | 98 | 6 | 23382219 | |
| Pubmed | Conditional deletion of beta1-integrin in astroglia causes partial reactive gliosis. | 7.16e-07 | 25 | 98 | 4 | 19373938 | |
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 10383933 | ||
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 7.53e-07 | 7 | 98 | 3 | 12846471 | |
| Pubmed | Differentiation of CD11c+ CX3CR1+ cells in the small intestine requires Notch signaling. | 7.53e-07 | 7 | 98 | 3 | 24711412 | |
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 10930463 | ||
| Pubmed | Abscence of laminin alpha1 chain in the skeletal muscle of dystrophic dy/dy mice. | 7.53e-07 | 7 | 98 | 3 | 9390664 | |
| Pubmed | 7.53e-07 | 7 | 98 | 3 | 14557481 | ||
| Pubmed | 8.45e-07 | 26 | 98 | 4 | 24742657 | ||
| Pubmed | Notch signaling prevents mucous metaplasia in mouse conducting airways during postnatal development. | 9.90e-07 | 27 | 98 | 4 | 21791528 | |
| Pubmed | 1.07e-06 | 64 | 98 | 5 | 22261194 | ||
| Pubmed | 1.10e-06 | 118 | 98 | 6 | 21078624 | ||
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 12015298 | ||
| Pubmed | EMILIN proteins are novel extracellular constituents of the dentin-pulp complex. | 1.20e-06 | 8 | 98 | 3 | 32948785 | |
| Pubmed | Laminin-1 promotes differentiation of fetal mouse pancreatic beta-cells. | 1.20e-06 | 8 | 98 | 3 | 10102687 | |
| Pubmed | Expression and localization of laminin-5 subunits during mouse tooth development. | 1.20e-06 | 8 | 98 | 3 | 9489770 | |
| Pubmed | P4 down-regulates Jagged2 and Notch1 expression during primordial folliculogenesis. | 1.20e-06 | 8 | 98 | 3 | 22652674 | |
| Pubmed | Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis. | 1.20e-06 | 8 | 98 | 3 | 15465493 | |
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 9858718 | ||
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 11044610 | ||
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 22156581 | ||
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 9852162 | ||
| Pubmed | Notch1 and Jagged1 expression by the developing pulmonary vasculature. | 1.20e-06 | 8 | 98 | 3 | 12242716 | |
| Pubmed | 1.20e-06 | 8 | 98 | 3 | 19651211 | ||
| Interaction | NTN5 interactions | 1.36e-13 | 24 | 96 | 8 | int:NTN5 | |
| Interaction | ZNF408 interactions | HSPG2 FBLN5 LAMA1 LRP1B CRELD1 FBN1 ZNF837 LRP2 LTBP1 LTBP2 LTBP4 NOTCH2 NOTCH3 | 1.94e-13 | 145 | 96 | 13 | int:ZNF408 |
| Interaction | FBLN2 interactions | 6.30e-13 | 66 | 96 | 10 | int:FBLN2 | |
| Interaction | ZFP41 interactions | 6.41e-12 | 57 | 96 | 9 | int:ZFP41 | |
| Interaction | IGFL3 interactions | 8.35e-11 | 75 | 96 | 9 | int:IGFL3 | |
| Interaction | MFAP5 interactions | 5.01e-09 | 52 | 96 | 7 | int:MFAP5 | |
| Interaction | FBXO2 interactions | HSPG2 LAMA1 LAMA5 LAMC2 LRP1B FBN1 JAG1 LRP2 NID1 PLAT LTBP4 NOTCH2 NOTCH3 | 7.62e-08 | 411 | 96 | 13 | int:FBXO2 |
| Interaction | NOTCH2 interactions | ROR1 ZNF696 FBLN1 ZNF497 JAG1 PLAT LTBP1 BRICD5 ZNF649 LTBP4 NOTCH2 NOTCH3 ZNF646 | 1.06e-07 | 423 | 96 | 13 | int:NOTCH2 |
| Interaction | FBLN1 interactions | 1.87e-07 | 129 | 96 | 8 | int:FBLN1 | |
| Interaction | ZNF707 interactions | 2.10e-06 | 79 | 96 | 6 | int:ZNF707 | |
| Interaction | NID1 interactions | 3.21e-06 | 48 | 96 | 5 | int:NID1 | |
| Interaction | LTBP2 interactions | 3.22e-06 | 85 | 96 | 6 | int:LTBP2 | |
| Interaction | FBN1 interactions | 4.36e-06 | 51 | 96 | 5 | int:FBN1 | |
| Interaction | LTBP1 interactions | 5.11e-06 | 92 | 96 | 6 | int:LTBP1 | |
| Interaction | HSPG2 interactions | 7.38e-06 | 98 | 96 | 6 | int:HSPG2 | |
| Interaction | HOXA1 interactions | FBLN5 LAMA5 CRELD1 FBLN1 FBN1 MEGF6 ZNF837 LTBP1 LTBP4 NOTCH3 | 7.65e-06 | 356 | 96 | 10 | int:HOXA1 |
| Interaction | ELN interactions | 1.05e-05 | 29 | 96 | 4 | int:ELN | |
| Interaction | ZNF517 interactions | 1.05e-05 | 29 | 96 | 4 | int:ZNF517 | |
| Interaction | FBLN5 interactions | 1.10e-05 | 159 | 96 | 7 | int:FBLN5 | |
| Interaction | ZNF444 interactions | 1.16e-05 | 106 | 96 | 6 | int:ZNF444 | |
| Interaction | HRG interactions | 1.25e-05 | 63 | 96 | 5 | int:HRG | |
| Interaction | LTBP4 interactions | 1.69e-05 | 67 | 96 | 5 | int:LTBP4 | |
| Interaction | ZNF74 interactions | 2.01e-05 | 34 | 96 | 4 | int:ZNF74 | |
| Interaction | CACNA1A interactions | 2.71e-05 | 123 | 96 | 6 | int:CACNA1A | |
| Interaction | ZDHHC15 interactions | 2.97e-05 | 125 | 96 | 6 | int:ZDHHC15 | |
| Interaction | ATN1 interactions | 3.15e-05 | 187 | 96 | 7 | int:ATN1 | |
| Interaction | ZNF526 interactions | 4.00e-05 | 80 | 96 | 5 | int:ZNF526 | |
| Interaction | NID2 interactions | 5.67e-05 | 86 | 96 | 5 | int:NID2 | |
| Interaction | ZNF497 interactions | 5.67e-05 | 44 | 96 | 4 | int:ZNF497 | |
| Interaction | PRG2 interactions | 6.56e-05 | 285 | 96 | 8 | int:PRG2 | |
| Interaction | ZNF324 interactions | 6.77e-05 | 46 | 96 | 4 | int:ZNF324 | |
| Interaction | ODAPH interactions | 8.69e-05 | 49 | 96 | 4 | int:ODAPH | |
| Interaction | CRKL interactions | 1.07e-04 | 227 | 96 | 7 | int:CRKL | |
| Interaction | ZNF224 interactions | 1.13e-04 | 20 | 96 | 3 | int:ZNF224 | |
| Interaction | ZNF627 interactions | 1.13e-04 | 20 | 96 | 3 | int:ZNF627 | |
| Interaction | TRIM68 interactions | 1.22e-04 | 101 | 96 | 5 | int:TRIM68 | |
| Interaction | EGFL6 interactions | 1.31e-04 | 21 | 96 | 3 | int:EGFL6 | |
| Interaction | GALNT14 interactions | 1.51e-04 | 22 | 96 | 3 | int:GALNT14 | |
| Interaction | ZNF77 interactions | 1.51e-04 | 22 | 96 | 3 | int:ZNF77 | |
| Interaction | ZNF282 interactions | 1.73e-04 | 23 | 96 | 3 | int:ZNF282 | |
| Interaction | LAMA2 interactions | 1.73e-04 | 23 | 96 | 3 | int:LAMA2 | |
| Interaction | JAG2 interactions | 1.82e-04 | 110 | 96 | 5 | int:JAG2 | |
| Interaction | ZNF765 interactions | 1.97e-04 | 24 | 96 | 3 | int:ZNF765 | |
| Interaction | NOTCH3 interactions | 2.07e-04 | 113 | 96 | 5 | int:NOTCH3 | |
| Interaction | COL7A1 interactions | 2.23e-04 | 25 | 96 | 3 | int:COL7A1 | |
| Interaction | PLAT interactions | 2.32e-04 | 63 | 96 | 4 | int:PLAT | |
| Interaction | DNAJC10 interactions | 2.46e-04 | 260 | 96 | 7 | int:DNAJC10 | |
| Interaction | VARS1 interactions | 2.46e-04 | 260 | 96 | 7 | int:VARS1 | |
| Interaction | FBN2 interactions | 2.62e-04 | 65 | 96 | 4 | int:FBN2 | |
| Interaction | LAMA1 interactions | 2.78e-04 | 66 | 96 | 4 | int:LAMA1 | |
| Interaction | ZNF320 interactions | 2.82e-04 | 27 | 96 | 3 | int:ZNF320 | |
| Interaction | ZNF696 interactions | 3.12e-04 | 68 | 96 | 4 | int:ZNF696 | |
| Interaction | PYHIN1 interactions | 3.12e-04 | 358 | 96 | 8 | int:PYHIN1 | |
| Interaction | GLI4 interactions | 3.30e-04 | 125 | 96 | 5 | int:GLI4 | |
| Interaction | ZNF430 interactions | 3.50e-04 | 29 | 96 | 3 | int:ZNF430 | |
| Interaction | COL4A3 interactions | 3.87e-04 | 30 | 96 | 3 | int:COL4A3 | |
| Interaction | LAMC2 interactions | 3.87e-04 | 30 | 96 | 3 | int:LAMC2 | |
| Interaction | CILP2 interactions | 4.27e-04 | 31 | 96 | 3 | int:CILP2 | |
| Interaction | ZNF749 interactions | 4.64e-04 | 7 | 96 | 2 | int:ZNF749 | |
| Interaction | ZNF253 interactions | 4.64e-04 | 7 | 96 | 2 | int:ZNF253 | |
| Interaction | ZNF594 interactions | 4.64e-04 | 7 | 96 | 2 | int:ZNF594 | |
| Interaction | ST14 interactions | 4.70e-04 | 207 | 96 | 6 | int:ST14 | |
| Interaction | GFI1B interactions | 4.86e-04 | 136 | 96 | 5 | int:GFI1B | |
| Cytoband | 19q13.43 | 1.29e-06 | 87 | 98 | 5 | 19q13.43 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF234 POLR2I ZNF416 ZNF547 FCGBP ZNF497 ZNF256 ZNF837 ZNF749 DMWD ZNF649 LTBP4 | 9.27e-06 | 1192 | 98 | 12 | chr19q13 |
| Cytoband | 3p24.3 | 1.53e-03 | 27 | 98 | 2 | 3p24.3 | |
| GeneFamily | Laminin subunits | 1.55e-07 | 12 | 78 | 4 | 626 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 3.08e-07 | 4 | 78 | 3 | 628 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.88e-05 | 41 | 78 | 4 | 1298 | |
| GeneFamily | CD molecules|Mucins | 9.71e-05 | 21 | 78 | 3 | 648 | |
| GeneFamily | Fibulins | 5.06e-04 | 8 | 78 | 2 | 556 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF234 ZNF696 ZNF416 ZNF547 ZNF497 ZNF256 ZNF837 ZNF749 ZNF649 ZNF646 | 1.01e-03 | 718 | 78 | 10 | 28 |
| GeneFamily | Low density lipoprotein receptors | 1.39e-03 | 13 | 78 | 2 | 634 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.91e-03 | 57 | 78 | 3 | 1179 | |
| Coexpression | NABA_MATRISOME | TPO HSPG2 RELN FBLN5 LAMA1 MUC19 LAMA2 LAMA5 LAMC2 BCAN TECTA ELFN2 FREM1 CRELD1 FBLN1 FBN1 SCUBE2 MEGF6 OTOGL P3H1 ADAMTS20 NID1 PLAT LTBP1 LTBP2 MUC2 VWA2 LTBP4 MUC5AC OTOG | 1.97e-19 | 1008 | 97 | 30 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | HSPG2 RELN FBLN5 LAMA1 LAMA2 LAMA5 LAMC2 BCAN TECTA CRELD1 FBLN1 FBN1 OTOGL NID1 LTBP1 LTBP2 VWA2 LTBP4 OTOG | 3.16e-19 | 270 | 97 | 19 | MM17057 |
| Coexpression | NABA_MATRISOME | TPO HSPG2 RELN FBLN5 LAMA1 MUC19 LAMA2 LAMA5 LAMC2 BCAN TECTA ELFN2 FREM1 CRELD1 FBLN1 FBN1 SCUBE2 MEGF6 P3H1 ADAMTS20 NID1 PLAT LTBP1 LTBP2 MUC2 VWA2 LTBP4 MUC5AC FBN3 OTOG | 3.22e-19 | 1026 | 97 | 30 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | HSPG2 RELN FBLN5 LAMA1 LAMA2 LAMA5 LAMC2 BCAN TECTA CRELD1 FBLN1 FBN1 NID1 LTBP1 LTBP2 VWA2 LTBP4 FBN3 OTOG | 4.47e-19 | 275 | 97 | 19 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | RELN FBLN5 LAMA1 LAMA2 LAMA5 LAMC2 TECTA CRELD1 FBLN1 FBN1 OTOGL NID1 LTBP1 LTBP2 VWA2 LTBP4 OTOG | 5.08e-19 | 191 | 97 | 17 | MM17059 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | RELN FBLN5 LAMA1 LAMA2 LAMA5 LAMC2 TECTA CRELD1 FBLN1 FBN1 NID1 LTBP1 LTBP2 VWA2 LTBP4 FBN3 OTOG | 7.92e-19 | 196 | 97 | 17 | M3008 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 2.11e-10 | 23 | 97 | 6 | M48001 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 7.61e-09 | 40 | 97 | 6 | M5887 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 9.28e-09 | 20 | 97 | 5 | MM17053 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | FBLN5 MAP1B LAMA5 RYR3 THBD FBLN1 FBN1 SCUBE2 C1R NID1 PLAT LTBP2 NOTCH3 | 4.62e-08 | 505 | 97 | 13 | M39167 |
| Coexpression | BOQUEST_STEM_CELL_UP | 4.74e-08 | 261 | 97 | 10 | M1834 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS | 1.23e-07 | 289 | 97 | 10 | M41750 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 1.86e-07 | 35 | 97 | 5 | MM17054 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | CD248 LAMA1 FBLN1 FBN1 P3H1 JAG1 C1R NID1 LTBP4 NOTCH2 NOTCH3 | 1.91e-07 | 385 | 97 | 11 | M39264 |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 2.72e-07 | 117 | 97 | 7 | M39300 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C1 | 6.55e-07 | 19 | 97 | 4 | M16026 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 8.08e-07 | 200 | 97 | 8 | M5930 | |
| Coexpression | VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 | 1.71e-06 | 54 | 97 | 5 | M4737 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | HSPG2 FBLN5 MAP1B CD248 FZD7 FBN1 FCGBP SCUBE2 C1R NID1 LTBP1 | 2.16e-06 | 493 | 97 | 11 | M19391 |
| Coexpression | DELYS_THYROID_CANCER_DN | 2.53e-06 | 233 | 97 | 8 | M13273 | |
| Coexpression | MOHANKUMAR_HOXA1_TARGETS_DN | 4.22e-06 | 176 | 97 | 7 | M9032 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_FAP_CELLS | 4.72e-06 | 179 | 97 | 7 | M41745 | |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 5.22e-06 | 257 | 97 | 8 | M13867 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 5.85e-06 | 32 | 97 | 4 | M5903 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 7.99e-06 | 194 | 97 | 7 | M39122 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | CD248 MARS1 LAMA2 FBN1 JAG1 C1R NID1 PLAT LTBP1 LTBP2 NOTCH2 NOTCH3 | 8.16e-06 | 681 | 97 | 12 | M39175 |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 8.45e-06 | 35 | 97 | 4 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 9.48e-06 | 36 | 97 | 4 | MM1212 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 1.22e-05 | 137 | 97 | 6 | M40313 | |
| Coexpression | TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL | 1.46e-05 | 296 | 97 | 8 | M41675 | |
| Coexpression | ONDER_CDH1_SIGNALING_VIA_CTNNB1 | 1.53e-05 | 84 | 97 | 5 | M15484 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 2.66e-05 | 16 | 97 | 3 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 2.66e-05 | 16 | 97 | 3 | M2207 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 3.56e-05 | 50 | 97 | 4 | M1259 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | RELN KCNH8 CD248 ROR1 LAMA1 LAMC2 BCAN KCNH3 FZD7 THBD SCUBE2 JAG1 LRP2 PROS1 | 4.06e-05 | 1074 | 97 | 14 | M1941 |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 4.16e-05 | 52 | 97 | 4 | MM1118 | |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN | 5.79e-05 | 465 | 97 | 9 | M9192 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 6.34e-05 | 268 | 97 | 7 | M45796 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 6.86e-05 | 59 | 97 | 4 | M47993 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL | 6.96e-05 | 115 | 97 | 5 | M45752 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 7.27e-05 | 479 | 97 | 9 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 7.74e-05 | 483 | 97 | 9 | MM1082 | |
| Coexpression | CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL | 8.36e-05 | 193 | 97 | 6 | M39321 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | TPO MUC19 ELFN2 FREM1 SCUBE2 MEGF6 P3H1 ADAMTS20 PLAT MUC2 MUC5AC | 9.04e-05 | 738 | 97 | 11 | MM17058 |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP | 9.89e-05 | 199 | 97 | 6 | M9410 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | TPO MUC19 ELFN2 FREM1 SCUBE2 MEGF6 P3H1 ADAMTS20 PLAT MUC2 MUC5AC | 1.05e-04 | 751 | 97 | 11 | M5885 |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER | 1.07e-04 | 25 | 97 | 3 | M47986 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS | 1.20e-04 | 26 | 97 | 3 | M47999 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | HSPG2 FZD7 FBLN1 FBN1 OTOGL JAG1 C1R NID1 LTBP2 TACR1 NOTCH3 | 1.27e-04 | 767 | 97 | 11 | M39209 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | FBLN5 LAMA2 TECTA CRB1 FBLN1 MEGF6 DLEC1 TACR1 LTBP4 ALK NOTCH3 SPINK5 | 1.34e-04 | 909 | 97 | 12 | M41018 |
| Coexpression | LEE_BMP2_TARGETS_UP | FBLN5 LAMA2 FZD7 THBD SLC15A2 JAG1 C1R PLAT LTBP1 LTBP4 NOTCH3 | 1.47e-04 | 780 | 97 | 11 | M2324 |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 1.48e-04 | 135 | 97 | 5 | M5825 | |
| Coexpression | HALLMARK_COAGULATION | 1.64e-04 | 138 | 97 | 5 | M5946 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 1.67e-04 | 29 | 97 | 3 | MM17055 | |
| Coexpression | LEE_BMP2_TARGETS_UP | FBLN5 LAMA2 FZD7 THBD SLC15A2 JAG1 C1R PLAT LTBP1 LTBP4 NOTCH3 | 1.93e-04 | 805 | 97 | 11 | MM1067 |
| Coexpression | WEST_ADRENOCORTICAL_TUMOR_DN | 1.95e-04 | 546 | 97 | 9 | M3837 | |
| Coexpression | WONG_ENDMETRIUM_CANCER_DN | 2.04e-04 | 78 | 97 | 4 | M1311 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | FBLN5 DPY19L2 BCAN GRM6 RYR3 KCNH3 THBD FBN1 LRP2 LTBP2 TACR1 DPY19L2P2 EPHA10 | 2.36e-04 | 1115 | 97 | 13 | M10371 |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | 2.57e-04 | 567 | 97 | 9 | M2129 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | 2.81e-04 | 574 | 97 | 9 | M39056 | |
| Coexpression | JONES_OVARY_STROMAL | 2.90e-04 | 156 | 97 | 5 | M48352 | |
| Coexpression | LIU_CDX2_TARGETS_UP | 2.95e-04 | 35 | 97 | 3 | M16637 | |
| Coexpression | NABA_ECM_AFFILIATED | 3.08e-04 | 158 | 97 | 5 | MM17063 | |
| Coexpression | LIU_VAV3_PROSTATE_CARCINOGENESIS_UP | 3.38e-04 | 89 | 97 | 4 | M215 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 3.39e-04 | 352 | 97 | 7 | M17471 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 3.55e-04 | 163 | 97 | 5 | M12112 | |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 3.74e-04 | 8 | 97 | 2 | M9884 | |
| Coexpression | FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON | 3.86e-04 | 166 | 97 | 5 | M39026 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 3.86e-04 | 166 | 97 | 5 | M1542 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | 3.89e-04 | 600 | 97 | 9 | M39055 | |
| Coexpression | JAEGER_METASTASIS_DN | 4.18e-04 | 260 | 97 | 6 | M10702 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 4.21e-04 | 365 | 97 | 7 | M39018 | |
| Coexpression | NABA_ECM_AFFILIATED | 4.31e-04 | 170 | 97 | 5 | M5880 | |
| Coexpression | TRAYNOR_RETT_SYNDROM_UP | 4.39e-04 | 40 | 97 | 3 | M2712 | |
| Coexpression | SMID_BREAST_CANCER_NORMAL_LIKE_UP | 4.45e-04 | 485 | 97 | 8 | M8513 | |
| Coexpression | JONES_OVARY_PERICYTE | 4.55e-04 | 172 | 97 | 5 | M48351 | |
| Coexpression | MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP | 4.62e-04 | 265 | 97 | 6 | M2255 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 5.07e-04 | 99 | 97 | 4 | M39152 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | HSPG2 RELN FBLN5 LAMA2 ZNF416 FZD7 SCUBE2 JAG1 C1R NEIL3 LTBP4 PROS1 | 5.15e-04 | 1054 | 97 | 12 | M45798 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_SMG_BASAL_CELL | 5.35e-04 | 380 | 97 | 7 | M45714 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 5.45e-04 | 179 | 97 | 5 | MM660 | |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN | 5.45e-04 | 179 | 97 | 5 | M8519 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 5.45e-04 | 179 | 97 | 5 | M39308 | |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_COL9A1_HIGH_CILIARY_BODY_CELLS | 5.47e-04 | 101 | 97 | 4 | M43627 | |
| Coexpression | CYCLIN_D1_UP.V1_UP | 6.64e-04 | 187 | 97 | 5 | M2654 | |
| Coexpression | MARCHINI_TRABECTEDIN_RESISTANCE_DN | 6.64e-04 | 46 | 97 | 3 | M8349 | |
| Coexpression | IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN | 6.79e-04 | 107 | 97 | 4 | M4913 | |
| Coexpression | TRAVAGLINI_LUNG_BASAL_CELL | 6.80e-04 | 188 | 97 | 5 | M41651 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL | 6.90e-04 | 286 | 97 | 6 | M45746 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5 | 7.04e-04 | 108 | 97 | 4 | M1281 | |
| Coexpression | JONES_OVARY_MAST_CELL | 7.08e-04 | 47 | 97 | 3 | M48356 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_1_CELL | 7.28e-04 | 109 | 97 | 4 | M45707 | |
| Coexpression | WANG_SMARCE1_TARGETS_UP | 7.96e-04 | 294 | 97 | 6 | M1804 | |
| Coexpression | GSE3982_BCELL_VS_NKCELL_DN | 8.40e-04 | 197 | 97 | 5 | M5548 | |
| Coexpression | CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS | 8.49e-04 | 50 | 97 | 3 | M1702 | |
| Coexpression | HEVNER_TELENCEPHALON_MENINGEAL_CELLS | 8.49e-04 | 50 | 97 | 3 | MM403 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED | 8.73e-04 | 12 | 97 | 2 | M47985 | |
| Coexpression | GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_UP | 8.98e-04 | 200 | 97 | 5 | M9551 | |
| Coexpression | GSE18148_CBFB_KO_VS_WT_TREG_DN | 8.98e-04 | 200 | 97 | 5 | M4252 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 9.30e-04 | 303 | 97 | 6 | M39040 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.17e-11 | 97 | 91 | 10 | GSM777043_100 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | HSPG2 RELN FBLN5 SH3GL3 LAMC2 THBD FBN1 JAG1 C1R NID1 PLAT LTBP1 LTBP2 LTBP4 PROS1 | 5.55e-10 | 439 | 91 | 15 | GSM777059_500 |
| CoexpressionAtlas | Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4 | HSPG2 RELN FBLN5 SH3GL3 THBD FBN1 JAG1 C1R NID1 PLAT LTBP1 LTBP2 LTBP4 PROS1 | 7.28e-09 | 450 | 91 | 14 | GSM777063_500 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | SH3GL3 LAMA1 LAMA5 LAMC2 ZNF416 FREM1 FZD7 FBLN1 FBN1 SLC15A2 JAG1 LRP2 PLAT NEIL3 LTBP1 TACR1 NOTCH2 | 3.23e-08 | 783 | 91 | 17 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | HSPG2 FBLN5 MAP1B LAMA2 LAMA5 THBD FBN1 JAG1 C1R NID1 LTBP4 NOTCH3 PROS1 | 6.76e-08 | 453 | 91 | 13 | GSM777067_500 |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | HSPG2 FBLN5 LAMA2 LAMA5 THBD FBLN1 FBN1 C1R NID1 LTBP1 LTBP4 NOTCH3 PROS1 | 9.38e-08 | 466 | 91 | 13 | GSM777050_500 |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | HSPG2 FBLN5 CD248 LAMA2 FBLN1 FBN1 C1R NID1 PLAT LTBP1 LTBP4 PROS1 | 3.61e-07 | 437 | 91 | 12 | GSM777046_500 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | HSPG2 LAMA2 THBD FBLN1 FBN1 JAG1 C1R NID1 PLAT LTBP1 LTBP4 PROS1 | 4.38e-07 | 445 | 91 | 12 | GSM777043_500 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.15e-07 | 293 | 91 | 10 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | HSPG2 FBLN5 THBD FBLN1 FBN1 JAG1 C1R NID1 LTBP2 LTBP4 NOTCH3 PROS1 | 5.54e-07 | 455 | 91 | 12 | GSM777055_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | FBLN5 CD248 DPY19L1 LAMA1 LAMA2 FREM1 THBD FBLN1 FBN1 P3H1 JAG1 NID1 LTBP4 NOTCH2 PROS1 | 9.53e-07 | 773 | 91 | 15 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | RELN FBLN5 CD248 ROR1 LAMA1 LAMA5 LAMC2 FZD7 FBN1 SLC15A2 JAG1 LRP2 NID1 LTBP1 NOTCH2 NOTCH3 | 1.35e-06 | 905 | 91 | 16 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 2.98e-06 | 356 | 91 | 10 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | RELN FBLN5 CD248 ROR1 LAMA5 FBN1 JAG1 LRP2 NID1 NOTCH2 NOTCH3 | 4.01e-06 | 456 | 91 | 11 | gudmap_kidney_P0_JuxtaGlom_Ren1_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_500 | MAP1B DPY19L1 ROR1 SH3GL3 LAMA2 RYR3 FZD7 FBLN1 ADAMTS20 NEIL3 | 7.13e-06 | 393 | 91 | 10 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 7.96e-06 | 398 | 91 | 10 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.34e-05 | 182 | 91 | 7 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.40e-05 | 336 | 91 | 9 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | CD248 DPY19L1 LAMA1 LAMA2 FREM1 THBD FBLN1 FBN1 P3H1 JAG1 NID1 LTBP4 NOTCH2 | 2.33e-05 | 768 | 91 | 13 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | MAP1B DPY19L1 ROR1 SH3GL3 LAMA2 RYR3 FZD7 FBLN1 SHPRH ADAMTS20 NEIL3 LTBP1 CNOT4 | 2.46e-05 | 772 | 91 | 13 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 2.57e-05 | 456 | 91 | 10 | GSM777032_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 2.72e-05 | 459 | 91 | 10 | GSM777037_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 2.72e-05 | 82 | 91 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 3.06e-05 | 207 | 91 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#4_top-relative-expression-ranked_500 | 5.49e-05 | 155 | 91 | 6 | gudmap_kidney_P0_JuxtaGlom_Ren1_k4_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#4_top-relative-expression-ranked_500 | 5.53e-05 | 95 | 91 | 5 | gudmap_kidney_P4_CapMesRenVes_Crym_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.61e-05 | 310 | 91 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 5.69e-05 | 156 | 91 | 6 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 6.11e-05 | 97 | 91 | 5 | GSM777046_100 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | FBLN5 MAP1B CD248 ROR1 SH3GL3 POLR2I LAMA2 FREM1 RYR3 FBLN1 FBN1 LTBP1 | 6.88e-05 | 734 | 91 | 12 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 7.77e-05 | 165 | 91 | 6 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.00e-04 | 337 | 91 | 8 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | CD248 LAMA1 LAMA2 FREM1 THBD FBLN1 FBN1 P3H1 JAG1 NID1 LTBP4 NOTCH2 | 1.18e-04 | 777 | 91 | 12 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.31e-04 | 261 | 91 | 7 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | DPY19L1 LAMA1 CRELD1 FBN1 SCUBE2 MEGF6 JAG1 LRP2 NID1 LTBP1 LTBP2 BRICD5 DMWD LTBP4 FBN3 NOTCH2 PROS1 | 1.45e-04 | 1466 | 91 | 17 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 1.61e-04 | 361 | 91 | 8 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO cord blood-Confounder_removed-fold2.0_adjp0.05 | 1.64e-04 | 189 | 91 | 6 | PCBC_ratio_ECTO blastocyst_vs_ECTO cord blood_cfr-2X-p05 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 1.75e-04 | 65 | 91 | 4 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.94e-04 | 195 | 91 | 6 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.40e-04 | 305 | 91 | 7 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000_k2 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | SH3GL3 LAMC2 ZNF416 FZD7 FBN1 SLC15A2 JAG1 NEIL3 LTBP1 TACR1 NOTCH2 | 3.55e-04 | 749 | 91 | 11 | gudmap_kidney_P3_CapMes_Crym_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200 | 4.15e-04 | 146 | 91 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 4.15e-04 | 146 | 91 | 5 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_500 | 4.28e-04 | 82 | 91 | 4 | gudmap_developingKidney_e15.5_Peripheral blastema_500_k3 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.42e-04 | 148 | 91 | 5 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.58e-04 | 229 | 91 | 6 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000_k3 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | FBLN5 CD248 LAMA2 THBD FBLN1 FBN1 LRP2 NID1 LTBP2 LTBP4 PROS1 | 4.89e-04 | 778 | 91 | 11 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 4.90e-04 | 85 | 91 | 4 | GSM777067_100 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 5.36e-04 | 87 | 91 | 4 | GSM777050_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_top-relative-expression-ranked_1000 | RELN LAMA1 LAMA5 LAMC2 CRELD1 SCUBE2 JAG1 LRP2 PLAT LTBP1 VWA2 | 6.90e-04 | 811 | 91 | 11 | gudmap_developingKidney_e15.5_S-shaped body_1000 |
| CoexpressionAtlas | kidney_e15.5_Podocyte_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.10e-04 | 249 | 91 | 6 | gudmap_kidney_e15.5_Podocyte_MafB_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#3 | 7.27e-04 | 567 | 91 | 9 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | IRF2BP2 MAP1B ROR1 RYR3 THBD SLC15A2 SHPRH ADAMTS20 LTBP1 ALK ZNF646 | 7.40e-04 | 818 | 91 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 7.44e-04 | 166 | 91 | 5 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 9.43e-04 | 175 | 91 | 5 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | 9.51e-04 | 589 | 91 | 9 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K1 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 9.68e-04 | 364 | 91 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | 1.06e-03 | 370 | 91 | 7 | gudmap_kidney_P3_CapMes_Crym_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.17e-03 | 607 | 91 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K2 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K2 | IRF2BP2 RELN FBLN5 DPY19L1 ROR1 SH3GL3 LAMA2 FREM1 FZD7 FBLN1 FBN1 SCUBE2 LTBP1 LTBP4 | 1.21e-03 | 1298 | 91 | 14 | gudmap_RNAseq_e15.5_Mesangium_2500_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_500 | 1.27e-03 | 187 | 91 | 5 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k5 | |
| CoexpressionAtlas | ECTO blastocyst_vs_ECTO amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 1.30e-03 | 280 | 91 | 6 | PCBC_ratio_ECTO blastocyst_vs_ECTO amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.34e-03 | 385 | 91 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.39e-03 | 191 | 91 | 5 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_200 | 1.53e-03 | 53 | 91 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200_k1 | |
| ToppCell | IPF-Stromal|IPF / Disease state, Lineage and Cell class | FBLN5 MAP1B CD248 ROR1 LAMA2 FBLN1 FBN1 C1R NID1 LTBP1 LTBP2 LTBP4 | 2.20e-14 | 198 | 98 | 12 | ece914c32c9b123b779aa9624b92e6230763a20e |
| ToppCell | cellseq-Mesenchymal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | FBLN5 MAP1B CD248 LAMA2 FBLN1 FBN1 C1R NID1 LTBP1 LTBP2 LTBP4 NOTCH3 | 2.48e-14 | 200 | 98 | 12 | 238285fc372ce2e5e4341fc3084a3a833bf4a0a6 |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | FBLN5 MAP1B CD248 LAMA2 FBLN1 FBN1 C1R NID1 LTBP1 LTBP2 LTBP4 NOTCH3 | 2.48e-14 | 200 | 98 | 12 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 |
| ToppCell | Biopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type | FBLN5 MAP1B CD248 LAMA2 FBLN1 FBN1 C1R NID1 LTBP1 LTBP2 LTBP4 NOTCH3 | 2.48e-14 | 200 | 98 | 12 | d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070 |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | FBLN5 MAP1B CD248 LAMA2 FBLN1 FBN1 C1R NID1 LTBP1 LTBP2 LTBP4 | 5.50e-13 | 193 | 98 | 11 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | FBLN5 MAP1B CD248 LAMA2 FBLN1 FBN1 C1R NID1 LTBP1 LTBP2 LTBP4 | 5.50e-13 | 193 | 98 | 11 | e2ee077fd381bd906e6b4329f22e7d106e422a7f |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | FBLN5 MAP1B CD248 LAMA2 FBLN1 FBN1 C1R NID1 LTBP1 LTBP2 LTBP4 | 6.16e-13 | 195 | 98 | 11 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | FBLN5 MAP1B CD248 LAMA2 FBLN1 FBN1 C1R NID1 LTBP1 LTBP2 LTBP4 | 6.88e-13 | 197 | 98 | 11 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 |
| ToppCell | COPD-Stromal|COPD / Disease state, Lineage and Cell class | FBLN5 MAP1B CD248 LAMA2 FBLN1 FBN1 C1R NID1 LTBP1 LTBP2 LTBP4 | 6.88e-13 | 197 | 98 | 11 | d5390d86acaa8c39f1da893e8d2271f9ed2951d7 |
| ToppCell | COPD-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | FBLN5 MAP1B CD248 LAMA2 FBLN1 FBN1 C1R NID1 PLAT LTBP1 LTBP4 | 7.27e-13 | 198 | 98 | 11 | 2f13c0b3372af53d1bd85f9546f315c878580a71 |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | HSPG2 FBLN5 CD248 LAMA2 FBLN1 FBN1 NID1 PLAT LTBP1 LTBP4 PROS1 | 7.27e-13 | 198 | 98 | 11 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 |
| ToppCell | Control-Stromal|Control / Disease state, Lineage and Cell class | FBLN5 CD248 LAMA2 FBLN1 FBN1 C1R NID1 PLAT LTBP1 LTBP2 LTBP4 | 7.27e-13 | 198 | 98 | 11 | ae726b6b7f0a4107899be4d32ac256ffa0bd8d59 |
| ToppCell | COPD-Stromal-Fibroblast|COPD / Disease state, Lineage and Cell class | FBLN5 MAP1B CD248 LAMA2 FBLN1 FBN1 C1R NID1 PLAT LTBP1 LTBP4 | 7.27e-13 | 198 | 98 | 11 | 7904af61473cb20064f7a3a1e1bfe8d5913cf317 |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | FBLN5 MAP1B CD248 LAMA2 FBLN1 FBN1 C1R NID1 LTBP1 LTBP2 LTBP4 | 7.69e-13 | 199 | 98 | 11 | fb580e9321ddf97c73b2e356cd82523db74a38a2 |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | FBLN5 MAP1B CD248 LAMA2 FBLN1 FBN1 C1R NID1 LTBP1 LTBP2 LTBP4 | 8.12e-13 | 200 | 98 | 11 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | FBLN5 MAP1B CD248 LAMA2 FBLN1 FBN1 C1R NID1 LTBP1 LTBP2 LTBP4 | 8.12e-13 | 200 | 98 | 11 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | FBLN5 MAP1B LAMA2 FREM1 FBLN1 FBN1 C1R NID1 LTBP1 LTBP2 LTBP4 | 8.12e-13 | 200 | 98 | 11 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Fibroblasts|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | FBLN5 MAP1B CD248 LAMA2 FBLN1 FBN1 C1R PLAT LTBP1 LTBP2 LTBP4 | 8.12e-13 | 200 | 98 | 11 | bfa73bc5f8a6c7de8353ca049a921ef19f7f4437 |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | FBLN5 MAP1B CD248 LAMA2 FBLN1 FBN1 C1R NID1 LTBP1 LTBP2 LTBP4 | 8.12e-13 | 200 | 98 | 11 | 0a86656d48e4238d0e4d592d477d29f7ba7c2ec0 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | FBLN5 MAP1B CD248 LAMA2 FBLN1 FBN1 C1R NID1 LTBP1 LTBP2 LTBP4 | 8.12e-13 | 200 | 98 | 11 | 3fa7d9ea67f9cc55478d085da53babd03dbe9bb1 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | FBLN5 MAP1B CD248 LAMA2 FBLN1 FBN1 C1R NID1 LTBP1 LTBP2 LTBP4 | 8.12e-13 | 200 | 98 | 11 | 1e75d1302c22e1b1666c19c0c9259d5cc8be16d5 |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.42e-12 | 182 | 98 | 10 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-11 | 184 | 98 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-11 | 184 | 98 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-11 | 184 | 98 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.37e-11 | 189 | 98 | 10 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.60e-11 | 192 | 98 | 10 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.68e-11 | 193 | 98 | 10 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.68e-11 | 193 | 98 | 10 | 25248b8e65d558b1a96a87c93e3e5b4c0ba168fe | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.68e-11 | 193 | 98 | 10 | f1f1097204e07a7bed416425b8256942038a734f | |
| ToppCell | facs-MAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-11 | 194 | 98 | 10 | f906b090f67df4cfe3498cdbb52cc0efa08e06cc | |
| ToppCell | facs-MAT-Fat-18m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-11 | 194 | 98 | 10 | 944cdb0403d80a10a2eea2a3516a9343dbccc32c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-11 | 194 | 98 | 10 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | facs-MAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-11 | 194 | 98 | 10 | 85081d255fcc1e9854c0073321dd9f0feaa48866 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-11 | 195 | 98 | 10 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.87e-11 | 195 | 98 | 10 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.87e-11 | 195 | 98 | 10 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.87e-11 | 195 | 98 | 10 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.87e-11 | 195 | 98 | 10 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | IPF-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 1.87e-11 | 195 | 98 | 10 | 9c32756edb54f0c211185d9a98073fe01fd1526a | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-11 | 195 | 98 | 10 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.87e-11 | 195 | 98 | 10 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-11 | 195 | 98 | 10 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-11 | 196 | 98 | 10 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-11 | 196 | 98 | 10 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | IPF-Stromal-Fibroblast|IPF / Disease state, Lineage and Cell class | 1.96e-11 | 196 | 98 | 10 | f7ae604ba32b322d86d68b2b54892e7c6ab06c49 | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.96e-11 | 196 | 98 | 10 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | Control-Stromal-Fibroblast|Control / Disease state, Lineage and Cell class | 1.96e-11 | 196 | 98 | 10 | 7ca94477498a84cafcdd9933ee92a6cbde76c70e | |
| ToppCell | Control-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 1.96e-11 | 196 | 98 | 10 | 1ec7a4daa51b3156db97e1fd6cb925ad311bb4b5 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-11 | 196 | 98 | 10 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-11 | 196 | 98 | 10 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.06e-11 | 197 | 98 | 10 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.06e-11 | 197 | 98 | 10 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-11 | 197 | 98 | 10 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.06e-11 | 197 | 98 | 10 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | distal-mesenchymal-Adventitial_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.17e-11 | 198 | 98 | 10 | bfd720e2dae3b6b3dc2bf8b2096c554fd456e756 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-11 | 198 | 98 | 10 | aae663c6da70b6e716edeed50cc7d3962d78e697 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.28e-11 | 199 | 98 | 10 | 5a425e7d11c5911ff5855c27a7f058a7ed7abbb0 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.28e-11 | 199 | 98 | 10 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | ASK452-Mesenchymal-Fibroblast|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.28e-11 | 199 | 98 | 10 | 4d0bf2a4bd97e5a3bfe4570a201cc21bb9c4c1f6 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.28e-11 | 199 | 98 | 10 | 66545eb7f65e450b742628fd431956e13330a0d3 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.28e-11 | 199 | 98 | 10 | f835e7ffe976843b0edbf695762d463da85793f3 | |
| ToppCell | ASK452-Mesenchymal|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.28e-11 | 199 | 98 | 10 | 93e85e3731a9ece9aee3eb82c5dfdad331ee62d6 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.28e-11 | 199 | 98 | 10 | 4e128c705ad36fd840582848f278770f356fcc8b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.28e-11 | 199 | 98 | 10 | 0019cfaa586a450c2e4952d1184a540561c8d0ba | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.28e-11 | 199 | 98 | 10 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.28e-11 | 199 | 98 | 10 | 993fa050a095017135a6e723c77cd38b9d782e58 | |
| ToppCell | (5)_Fibroblast-D|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.28e-11 | 199 | 98 | 10 | 3f415620ad8b8d8c6871e1353e13f87b281fcc0e | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.40e-11 | 200 | 98 | 10 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.40e-11 | 200 | 98 | 10 | 01522ed0b68614b1ebdf190957d44a9d48a6c6e3 | |
| ToppCell | 343B-Fibroblasts|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-11 | 200 | 98 | 10 | 376c1a77031e090be96948b47c78ac0d393f5775 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.40e-11 | 200 | 98 | 10 | a637281d91e95734ee4f8510b3780e0272b16fda | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-11 | 200 | 98 | 10 | 3e6730c9ed7003a4acf501f699a4965a7a50f946 | |
| ToppCell | (5)_Fibroblasts|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.40e-11 | 200 | 98 | 10 | 22c839f27d3abdf86bfabdfa305f205dd899a9dc | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.40e-11 | 200 | 98 | 10 | 954fee8425673e76198be414f5f6c4e3597c1919 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-11 | 200 | 98 | 10 | 2e4ab7fbd94d3d865ef6188d3b4916d2bf1b8d89 | |
| ToppCell | Biopsy_IPF-Mesenchymal-Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 2.40e-11 | 200 | 98 | 10 | d8637f1e62d3fb9476dc51e1b1dc2f4b14b5fcd8 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.40e-11 | 200 | 98 | 10 | b04831708fa20471a127b87e8db3728b6e729ce8 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.40e-11 | 200 | 98 | 10 | 6316c288022719b9e6c4332c5cb9041e1188d0e8 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_adventitial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.40e-11 | 200 | 98 | 10 | 9dd2eb70c1cc146935f5aff27373dfc65cb8c098 | |
| ToppCell | 367C-Fibroblasts|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-11 | 200 | 98 | 10 | c5aaa20c59b9f11b8abdf5de9e3fc54f4e6e39f7 | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.40e-11 | 200 | 98 | 10 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | Biopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 2.40e-11 | 200 | 98 | 10 | c2c6f687c49ba790174b27c7b8b084af30b34c86 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.40e-11 | 200 | 98 | 10 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.71e-11 | 160 | 98 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.71e-11 | 160 | 98 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-10 | 182 | 98 | 9 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-10 | 182 | 98 | 9 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.75e-10 | 182 | 98 | 9 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.88e-10 | 183 | 98 | 9 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.02e-10 | 184 | 98 | 9 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.02e-10 | 184 | 98 | 9 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.02e-10 | 184 | 98 | 9 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-10 | 187 | 98 | 9 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-10 | 187 | 98 | 9 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-10 | 187 | 98 | 9 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.66e-10 | 188 | 98 | 9 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.66e-10 | 188 | 98 | 9 | e18065bbc26d6f3774fd1f478fb41d8fb555fa26 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-10 | 189 | 98 | 9 | bc54ffd7bd1627a36747a80ce5139e4a69928400 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.84e-10 | 189 | 98 | 9 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| Computational | Metal / Ca ion binding. | 5.80e-07 | 133 | 59 | 8 | MODULE_324 | |
| Computational | ECM and collagens. | 2.88e-05 | 225 | 59 | 8 | MODULE_47 | |
| Computational | Adhesion molecules. | 1.17e-04 | 141 | 59 | 6 | MODULE_122 | |
| Computational | Genes in the cancer module 287. | 1.56e-04 | 50 | 59 | 4 | MODULE_287 | |
| Drug | AC1L1G72 | 9.98e-08 | 11 | 97 | 4 | CID000003553 | |
| Drug | kalinin | 1.25e-07 | 55 | 97 | 6 | CID000032518 | |
| Drug | pyrachlostrobin | HSPG2 FBLN5 CD248 ROR1 LAMA5 KCNH3 FZD7 FBN1 LRP2 NID1 LTBP1 LTBP2 EPHA10 NOTCH2 NOTCH3 PROS1 | 3.10e-07 | 811 | 97 | 16 | ctd:C513428 |
| Drug | Rgd Peptide | 8.53e-07 | 239 | 97 | 9 | CID000104802 | |
| Drug | YIGSR | 1.11e-06 | 79 | 97 | 6 | CID000123977 | |
| Drug | AC1L9FMG | 2.59e-06 | 7 | 97 | 3 | CID000444053 | |
| Drug | LG 5 | 5.74e-06 | 60 | 97 | 5 | CID011840957 | |
| Drug | AC1L1B58 | 6.77e-06 | 29 | 97 | 4 | CID000001288 | |
| Drug | AC1L1C2F | 7.67e-06 | 110 | 97 | 6 | CID000001711 | |
| Drug | Urokinase | 8.80e-06 | 10 | 97 | 3 | DB00013 | |
| Drug | quinocetone | 1.11e-05 | 248 | 97 | 8 | ctd:C502851 | |
| Drug | Trichlormethiazide [133-67-5]; Up 200; 10.6uM; HL60; HT_HG-U133A | 1.97e-05 | 194 | 97 | 7 | 2998_UP | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 2.03e-05 | 195 | 97 | 7 | 7219_UP | |
| Drug | Clofazimine [2030-63-9]; Up 200; 8.4uM; PC3; HT_HG-U133A | 2.03e-05 | 195 | 97 | 7 | 4682_UP | |
| Drug | Calcort | 2.04e-05 | 38 | 97 | 4 | CID000026709 | |
| Drug | Ikvav | 2.04e-05 | 38 | 97 | 4 | CID000131343 | |
| Drug | Cefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; HL60; HT_HG-U133A | 2.10e-05 | 196 | 97 | 7 | 2988_UP | |
| Drug | rhamnose | 2.15e-05 | 356 | 97 | 9 | CID000000840 | |
| Drug | Fosfosal [6064-83-1]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 2.17e-05 | 197 | 97 | 7 | 3336_DN | |
| Drug | Methylhydantoin-5-(L) [40856-73-3]; Up 200; 35uM; HL60; HT_HG-U133A | 2.17e-05 | 197 | 97 | 7 | 3040_UP | |
| Drug | G 3012 | 2.17e-05 | 132 | 97 | 6 | CID000120739 | |
| Drug | Butamben [94-25-7]; Up 200; 20.6uM; MCF7; HT_HG-U133A | 2.32e-05 | 199 | 97 | 7 | 6093_UP | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 2.39e-05 | 200 | 97 | 7 | 3182_UP | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 2.82e-05 | 83 | 97 | 5 | CID011968896 | |
| Drug | 1,2-dimethylhydrazine | 3.35e-05 | 86 | 97 | 5 | CID000001322 | |
| Drug | I-Q-S | 5.55e-05 | 156 | 97 | 6 | CID000003540 | |
| Drug | funiferine N-oxide | 5.66e-05 | 49 | 97 | 4 | CID000191631 | |
| Drug | norgestimate, ethinyl estradiol drug combination | 1.07e-04 | 4 | 97 | 2 | ctd:C109079 | |
| Drug | gamma-secretase inhibitor I | 1.07e-04 | 4 | 97 | 2 | CID011754711 | |
| Drug | CC270 | 1.18e-04 | 59 | 97 | 4 | CID006918852 | |
| Drug | AC1L9INI | 1.18e-04 | 59 | 97 | 4 | CID000445839 | |
| Drug | LMWH | HSPG2 LAMA1 LAMA2 LAMA5 LAMC2 RYR3 THBD FBLN1 LRP2 PLAT PROS1 | 1.21e-04 | 663 | 97 | 11 | CID000000772 |
| Drug | Sikvav | 1.42e-04 | 24 | 97 | 3 | CID005487517 | |
| Drug | A25152 | 1.43e-04 | 62 | 97 | 4 | CID000002956 | |
| Drug | 1-piperidinocyclohexanecarbonitrile | 1.61e-04 | 25 | 97 | 3 | CID000062529 | |
| Drug | 2-(4-nitrophenyl)benzoxazole | 1.78e-04 | 5 | 97 | 2 | CID000070047 | |
| Drug | Trifluridine [70-00-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 1.79e-04 | 193 | 97 | 6 | 7176_UP | |
| Drug | EGRck | 1.82e-04 | 26 | 97 | 3 | CID000122261 | |
| Drug | Gestodene | 1.82e-04 | 26 | 97 | 3 | ctd:C033273 | |
| Drug | (+/-)-blebbistatin; Up 200; 17uM; MCF7; HT_HG-U133A_EA | 1.84e-04 | 194 | 97 | 6 | 954_UP | |
| Drug | Mebeverine hydrochloride [2753-45-9]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.84e-04 | 194 | 97 | 6 | 3193_DN | |
| Drug | 16-phenyl tetranor Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 1.89e-04 | 195 | 97 | 6 | 7509_DN | |
| Drug | Remoxipride Hydrochloride [73220-03-8]; Up 200; 9.8uM; HL60; HT_HG-U133A | 1.89e-04 | 195 | 97 | 6 | 3124_UP | |
| Drug | Isoniazid [54-85-3]; Down 200; 29.2uM; PC3; HT_HG-U133A | 1.89e-04 | 195 | 97 | 6 | 5840_DN | |
| Drug | Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A | 1.89e-04 | 195 | 97 | 6 | 2875_UP | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 1.89e-04 | 195 | 97 | 6 | 4124_UP | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; MCF7; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 3333_DN | |
| Drug | Lovastatin [75330-75-5]; Up 200; 9.8uM; HL60; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 2494_UP | |
| Drug | Isosorbide dinitrate [87-33-2]; Up 200; 17uM; PC3; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 3720_UP | |
| Drug | Amikacin hydrate [37517-28-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 3233_DN | |
| Drug | Benzthiazide [91-33-8]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 6607_UP | |
| Drug | Nitrofurantoin [67-20-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 4697_DN | |
| Drug | Molsidomine [25717-80-0]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 2862_UP | |
| Drug | Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 2296_UP | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 2324_UP | |
| Drug | radicicol; Down 200; 0.1uM; SKMEL5; HG-U133A | 2.00e-04 | 197 | 97 | 6 | 493_DN | |
| Drug | Glipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 1508_DN | |
| Drug | Iodixanol [92339-11-2]; Up 200; 2.6uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 3362_UP | |
| Drug | Solasodine [126-17-0]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 4305_UP | |
| Drug | Austricine [10180-88-8]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 4797_UP | |
| Drug | Cefotiam hydrochloride; Up 200; 7.2uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 3319_UP | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 2237_UP | |
| Drug | Minoxidil [38304-91-5]; Up 200; 19.2uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 4800_UP | |
| Drug | Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 6001_UP | |
| Drug | Oxybenzone [131-57-7]; Up 200; 17.6uM; PC3; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 6309_UP | |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Up 200; 8uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 3170_UP | |
| Drug | Methacholine chloride [62-51-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 6248_UP | |
| Drug | AG-013608 [351320-38-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 5944_UP | |
| Drug | Mifepristone [84371-65-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 3185_UP | |
| Drug | Fusidic acid sodium salt [751-94-0]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 2647_DN | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 6786_UP | |
| Drug | Zoxazolamine [61-80-3]; Down 200; 23.8uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 2625_DN | |
| Drug | Suprofen [40828-46-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 3343_UP | |
| Drug | Mimosine [500-44-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 2.11e-04 | 199 | 97 | 6 | 5302_DN | |
| Drug | carmustine; Down 200; 100uM; MCF7; HT_HG-U133A | 2.11e-04 | 199 | 97 | 6 | 6888_DN | |
| Drug | Niflumic acid [4394-00-7]; Down 200; 14.2uM; HL60; HT_HG-U133A | 2.11e-04 | 199 | 97 | 6 | 2399_DN | |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 2.11e-04 | 199 | 97 | 6 | 3353_UP | |
| Drug | Proxyphylline [603-00-9]; Up 200; 16.8uM; PC3; HT_HG-U133A | 2.11e-04 | 199 | 97 | 6 | 7290_UP | |
| Drug | ICI182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 2.17e-04 | 200 | 97 | 6 | 7534_UP | |
| Drug | 2,3-pentanedione | 2.29e-04 | 129 | 97 | 5 | ctd:C013186 | |
| Drug | NSC692750 | 2.66e-04 | 6 | 97 | 2 | CID000078910 | |
| Drug | vgBE | 2.66e-04 | 6 | 97 | 2 | CID000193461 | |
| Drug | AC1L1C6R | 2.66e-04 | 6 | 97 | 2 | CID000001765 | |
| Drug | diisopropylphosphate | 2.80e-04 | 30 | 97 | 3 | CID000074162 | |
| Drug | inogatran | 2.80e-04 | 30 | 97 | 3 | CID000066005 | |
| Drug | dysprosium | 2.83e-04 | 74 | 97 | 4 | CID000023912 | |
| Disease | Hepatic ductular hypoplasia | 9.62e-06 | 2 | 92 | 2 | C2930797 | |
| Disease | Alagille syndrome (is_implicated_in) | 9.62e-06 | 2 | 92 | 2 | DOID:9245 (is_implicated_in) | |
| Disease | Alagille Syndrome 2 | 9.62e-06 | 2 | 92 | 2 | C1857761 | |
| Disease | Alagille Syndrome 1 | 9.62e-06 | 2 | 92 | 2 | C1956125 | |
| Disease | cystitis (is_marker_for) | 9.62e-06 | 2 | 92 | 2 | DOID:1679 (is_marker_for) | |
| Disease | Alagille Syndrome | 9.62e-06 | 2 | 92 | 2 | C0085280 | |
| Disease | Arteriohepatic dysplasia | 9.62e-06 | 2 | 92 | 2 | cv:C0085280 | |
| Disease | sputum mucin-5B amount | 2.88e-05 | 3 | 92 | 2 | OBA_2050332 | |
| Disease | Weill-Marchesani syndrome | 2.88e-05 | 3 | 92 | 2 | C0265313 | |
| Disease | cutis laxa (implicated_via_orthology) | 2.88e-05 | 3 | 92 | 2 | DOID:3144 (implicated_via_orthology) | |
| Disease | connective tissue disease (implicated_via_orthology) | 2.88e-05 | 3 | 92 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 2.88e-05 | 3 | 92 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 2.88e-05 | 3 | 92 | 2 | C1869114 | |
| Disease | Weill-Marchesani syndrome | 5.75e-05 | 4 | 92 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 5.75e-05 | 4 | 92 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | cutis laxa (is_implicated_in) | 5.75e-05 | 4 | 92 | 2 | DOID:3144 (is_implicated_in) | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 9.56e-05 | 5 | 92 | 2 | DOID:3030 (is_marker_for) | |
| Disease | FEV/FEC ratio | HSPG2 SH3GL3 LAMC2 SEPTIN2 CRELD1 FBLN1 FBN1 FCGBP MEGF6 LTBP1 DLEC1 LTBP2 LTBP4 | 1.11e-04 | 1228 | 92 | 13 | EFO_0004713 |
| Disease | Glioblastoma | 1.11e-04 | 79 | 92 | 4 | C0017636 | |
| Disease | Nonsyndromic Deafness | 1.23e-04 | 81 | 92 | 4 | C3711374 | |
| Disease | Malignant neoplasm of breast | ROR1 LAMA2 TECTA GRM6 PRICKLE3 OTOGL JAG1 DLEC1 ALK NOTCH2 NOTCH3 ZNF646 | 1.26e-04 | 1074 | 92 | 12 | C0006142 |
| Disease | Giant Cell Glioblastoma | 1.41e-04 | 84 | 92 | 4 | C0334588 | |
| Disease | Cutis Laxa | 1.43e-04 | 6 | 92 | 2 | C0010495 | |
| Disease | Leber congenital amaurosis (is_implicated_in) | 1.43e-04 | 6 | 92 | 2 | DOID:14791 (is_implicated_in) | |
| Disease | adenocarcinoma (implicated_via_orthology) | 2.00e-04 | 7 | 92 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 2.00e-04 | 7 | 92 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 3.41e-04 | 9 | 92 | 2 | EFO_0009824 | |
| Disease | margarate 17:0 measurement | 3.41e-04 | 9 | 92 | 2 | EFO_0021066 | |
| Disease | lower face morphology measurement | 3.83e-04 | 109 | 92 | 4 | EFO_0010948 | |
| Disease | Thrombus | 4.04e-04 | 46 | 92 | 3 | C0087086 | |
| Disease | Glioblastoma Multiforme | 4.11e-04 | 111 | 92 | 4 | C1621958 | |
| Disease | allergic rhinitis (biomarker_via_orthology) | 4.26e-04 | 10 | 92 | 2 | DOID:4481 (biomarker_via_orthology) | |
| Disease | optic disc size measurement | 4.64e-04 | 205 | 92 | 5 | EFO_0004832 | |
| Disease | Thrombosis | 4.87e-04 | 49 | 92 | 3 | C0040053 | |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 5.19e-04 | 11 | 92 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | Marfan Syndrome | 5.19e-04 | 11 | 92 | 2 | C0024796 | |
| Disease | Pulmonary Thromboembolisms | 6.22e-04 | 12 | 92 | 2 | C0524702 | |
| Disease | Pulmonary Embolism | 6.22e-04 | 12 | 92 | 2 | C0034065 | |
| Disease | Charcot-Marie-Tooth disease (is_implicated_in) | 6.22e-04 | 12 | 92 | 2 | DOID:10595 (is_implicated_in) | |
| Disease | Thromboembolism | 6.22e-04 | 12 | 92 | 2 | C0040038 | |
| Disease | Respiratory Distress Syndrome, Adult | 6.84e-04 | 55 | 92 | 3 | C0035222 | |
| Disease | Respiratory Depression | 7.33e-04 | 13 | 92 | 2 | C0235063 | |
| Disease | Respiratory Insufficiency | 7.33e-04 | 13 | 92 | 2 | C0035229 | |
| Disease | Respiratory Failure | 7.33e-04 | 13 | 92 | 2 | C1145670 | |
| Disease | pallidum volume change measurement | 7.33e-04 | 13 | 92 | 2 | EFO_0021494 | |
| Disease | Metabolic Bone Disorder | 8.54e-04 | 14 | 92 | 2 | C0005944 | |
| Disease | Osteopenia | 9.83e-04 | 15 | 92 | 2 | C0029453 | |
| Disease | intraocular pressure measurement | 1.08e-03 | 509 | 92 | 7 | EFO_0004695 | |
| Disease | melanoma | 1.09e-03 | 248 | 92 | 5 | C0025202 | |
| Disease | thrombomodulin measurement | 1.27e-03 | 17 | 92 | 2 | EFO_0007774 | |
| Disease | Eye Abnormalities | 1.27e-03 | 17 | 92 | 2 | C0015393 | |
| Disease | brain infarction | 1.42e-03 | 18 | 92 | 2 | EFO_0004277 | |
| Disease | ischemia (biomarker_via_orthology) | 1.42e-03 | 18 | 92 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | Non-Small Cell Lung Carcinoma | 1.46e-03 | 156 | 92 | 4 | C0007131 | |
| Disease | Colorectal Carcinoma | 1.59e-03 | 702 | 92 | 8 | C0009402 | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 1.76e-03 | 20 | 92 | 2 | DOID:2921 (biomarker_via_orthology) | |
| Disease | Manic | 1.88e-03 | 78 | 92 | 3 | C0338831 | |
| Disease | sex interaction measurement, cerebral amyloid angiopathy | 1.94e-03 | 21 | 92 | 2 | EFO_0006790, EFO_0008343 | |
| Disease | attempted suicide | 2.37e-03 | 178 | 92 | 4 | EFO_0004321 | |
| Disease | cortical thickness | IRF2BP2 HSPG2 RELN ROR1 LAMA1 LAMA2 FBN1 JAG1 ADAMTS20 DLEC1 | 2.46e-03 | 1113 | 92 | 10 | EFO_0004840 |
| Disease | Sjogren's syndrome (is_marker_for) | 2.54e-03 | 24 | 92 | 2 | DOID:12894 (is_marker_for) | |
| Disease | Carcinoma, Pancreatic Ductal | 2.54e-03 | 24 | 92 | 2 | C0887833 | |
| Disease | carotid artery intima media thickness | 2.88e-03 | 450 | 92 | 6 | EFO_0007117 | |
| Disease | brain cancer (implicated_via_orthology) | 2.98e-03 | 26 | 92 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | methionine measurement | 2.98e-03 | 26 | 92 | 2 | EFO_0009771 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EGFRPVEQCNLDYCP | 146 | Q9NXW9 | |
| VLFDGQSGCICYRPE | 106 | Q6PL45 | |
| VDGYLCQFGFEGACP | 151 | Q9HCU0 | |
| IGSFRCECPAGFNYN | 1741 | Q75N90 | |
| VNTDGSFRCECPFGY | 2101 | Q75N90 | |
| GYFCSCRPGYELQED | 171 | P00736 | |
| VCFNLGRELYFYPGC | 126 | Q09019 | |
| LQDFFQCGTYVCPDA | 306 | Q2TB18 | |
| GDCYSAFRCPQGQFS | 1836 | P59510 | |
| PRLVICCEGNAGFYE | 171 | Q9H3Z7 | |
| DYDERGFCVLGDLCQ | 281 | Q9P2N5 | |
| PAGEYEFQCLCRDGF | 4121 | P98160 | |
| FVAYEECRALCEGPY | 236 | Q32P28 | |
| VAGLFPVVYCSDGFC | 36 | Q9ULD8 | |
| PVVYCSDGFCDLTGF | 41 | Q9ULD8 | |
| FYDRILCDVPCSGDG | 261 | Q08J23 | |
| YGGDLCDVGLRFCNP | 676 | Q96GW7 | |
| DFIGGYRCECVPGYQ | 1166 | Q04721 | |
| ACGQCGLGYFEAERN | 191 | Q96HD1 | |
| LAFCGPNVLDSFYCD | 166 | O95013 | |
| ESPQCGYRQCGTEEF | 2836 | Q9NZR2 | |
| CCYIFPGGRGDSALF | 261 | P46821 | |
| YACPLPREAQCGFFE | 531 | Q8TAT5 | |
| DGDFICPDYYEAVCG | 106 | Q9NQ38 | |
| AGSYDCTCPDGFQLD | 1181 | Q14766 | |
| FCGPNVIDNFLCDLY | 196 | Q8NGL6 | |
| VFPNDCPCSFGGREY | 1231 | Q7Z5P9 | |
| PGLCDYNFASDCRGS | 56 | Q02817 | |
| FQCLCADPYELGDDG | 821 | P07202 | |
| PGTFRCECVEGYQFS | 731 | P14543 | |
| IFGIIGCGYFDPCRS | 2606 | Q96JB1 | |
| VSDGEAGPFVNGCCY | 981 | Q5H8C1 | |
| PDGYECRCAEGFEGT | 526 | Q9UM47 | |
| DGINRYDCVCQPGFT | 636 | Q9UM47 | |
| IESCEGLGDPACFYV | 146 | Q2PZI1 | |
| RYCELCADGYFGDAV | 896 | P24043 | |
| NEFSCGNGECIPRAY | 186 | P98164 | |
| GRCVPNYYLCDGVDD | 1036 | P98164 | |
| TFDGDVFRFPGLCNY | 91 | P98088 | |
| QERGDFCEACPPGFY | 276 | Q5JZY3 | |
| PNFSGERCDVCAEGF | 451 | O15230 | |
| EVQSCEGLGDPACFY | 231 | Q6NUT2 | |
| VAGLCPRDFEDYGCT | 86 | Q02509 | |
| AIDNFYLGPGCLDNC | 2846 | P78509 | |
| FFCAQCGAFFGPEGF | 441 | P49023 | |
| FCCFECEASLGGQRY | 276 | O43900 | |
| QGGFRCLAFECPENY | 546 | P23142 | |
| GLYRCEKCDTEFPNF | 496 | P27694 | |
| GYRFLGERDCGAPCE | 221 | O75084 | |
| YRFQVDEFTCEACPG | 546 | O15303 | |
| CPEDRLEQYEGPGFC | 4266 | Q9Y6R7 | |
| VGSFRCECPVGFFYN | 1786 | P35555 | |
| DGSYRCECPFGYILA | 2146 | P35555 | |
| DCTEVSPYCLLFFGG | 901 | Q9H2U1 | |
| VREGYTCDCFEGFQL | 1751 | Q14767 | |
| RGGYTCVCPDGFLLD | 376 | Q8N2S1 | |
| DCTFGACLRPEEYGV | 511 | Q8N7U6 | |
| ARCELCADGYFGDPF | 491 | Q13753 | |
| GSFICRCDPGYELEE | 226 | Q9UBX5 | |
| DALGAYFCDCAPGFL | 241 | P82279 | |
| CQYIVQFFPDCLGDF | 436 | Q9Y238 | |
| GEYSADGFAPCQLCA | 701 | Q9NQ36 | |
| RGDVQCFGEDCYALA | 206 | Q16348 | |
| CFGEDCYALAFGVPG | 211 | Q16348 | |
| DFTEPVCRGCVNYEG | 31 | Q7Z5L9 | |
| EVQSCEGLRDPACFY | 41 | Q6ZN68 | |
| FPGNCSYIFAKDCGD | 141 | Q3ZCN5 | |
| YYGFGCNKFCRPRDD | 191 | P78504 | |
| CVDGCYCPNGLIFED | 451 | Q6ZRI0 | |
| YCPNGLIFEDGGCVA | 456 | Q6ZRI0 | |
| LAFCGPNVLDSFYCD | 166 | Q6IEY1 | |
| PGFQGPRCQYDVDEC | 151 | O75095 | |
| GFECHCYPNYDLVDG | 346 | P07204 | |
| DQPCCRGLYDFEPEN | 286 | Q99963 | |
| GRACDQCSLGYRDFP | 1071 | P25391 | |
| RCCPFISAGDYEGLE | 321 | P25103 | |
| TYEPGFVGIRFCQEC | 6 | P36954 | |
| PFNTSDYRFECICGE | 651 | Q149N8 | |
| ICGRDDIEYFSPCFA | 516 | Q86UG4 | |
| QLIECRCCYGEFPFE | 511 | Q9NWF9 | |
| RCCYGEFPFEELTQC | 516 | Q9NWF9 | |
| PGDFECECPEGYRYN | 221 | P07225 | |
| RYGLECSFDFPCELE | 261 | Q9UM73 | |
| CRKLPVGFYCNFEDG | 471 | Q9UM73 | |
| LEIDDINFFPCTCGY | 21 | O95628 | |
| PAQRLYACDECGKAF | 266 | Q96EG3 | |
| EDGFCQPYRGIACAR | 166 | Q01973 | |
| CAVEDGYQGCFPKRE | 696 | O75443 | |
| GERPFECAECGQAFV | 326 | Q6ZNH5 | |
| LYFSDFVCQCPEGFA | 101 | P00750 | |
| GERPYECSECGKFFR | 636 | O43361 | |
| PYCGPDEIDNFFCDV | 171 | P0C645 | |
| CGDIHGQFYDLCELF | 51 | O00743 | |
| DGRYLVDGVPFSCCN | 201 | P23942 | |
| CFICGIGNDYFDTTP | 4791 | Q15413 | |
| ERPYECNECGKFFSQ | 516 | Q9Y2P7 | |
| DGYQCLCPLAFGGEA | 316 | Q5GFL6 | |
| GENPYECRECGQAFS | 261 | Q9H7X3 | |
| SGLEEYRPFRCGDCG | 366 | O15015 | |
| ERLFYVGDGANDFCP | 196 | Q8TCT1 | |
| GEKPYNCEECGRAFI | 256 | Q14588 | |
| PYECGECGKLFRQSF | 381 | Q9BWM5 | |
| ERPYECNECGKFFSL | 321 | Q8IVP9 | |
| DTPGYGDAINCRDCF | 101 | Q15019 | |
| LADRFVEGVCPFCGY | 396 | P56192 | |
| VEGVCPFCGYEEARG | 401 | P56192 | |
| PFCGYEEARGDQCDK | 406 | P56192 | |
| GERPYGCDECEKAYF | 426 | Q9BS31 | |
| ELAGNPFNCECDLFG | 181 | Q5R3F8 | |
| PIVYCSDGFCELAGF | 41 | Q96L42 |